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ABSTRACT 
Background: Pityriasis versicolor (PV) is a superficial mycosis, highly prevalent 
among teenagers living in the tropics. Malassezia is the etiological agent of PV. 
Fourteen species have been identified worldwide. So far, the debate is on which 
species is more prevalent and how the clinical presentations of PV differ 
geographically.  
Objective: To investigate the most prevalent Malassezia causing PV in Nigerian 
students, describe its clinico-epidemiological characteristics and estimate its effect 
on health related quality of life (HRQoL). 
Methodology: Students were recruited from senior secondary schools within the 
period of May 2012 to May 2013. Their clinical characteristics were described and 
scales obtained from PV lesions and non-lesions. The Children’s Dermatology Life 
Quality Index questionnaire was used to assess HRQoL. Malassezia species were 
identified using a molecular method. Results were analysed using SPSS package 
version 16. 
Results: The students recruited were 304. They had an average age of 16 years. 
The age of onset of PV was influenced by a positive family history, socioeconomic 
status, the daily use of petrolatum and concomitant presence of dandruff. The 
recurrence of PV and the color of the lesions which was majorly hypopigmented, 
were not related to differences in personal hygiene or family history of PV. The 
location of the lesions was predominately on face while the extent of distribution of 
the lesion was significantly linked with pruritus and dysesthesia. A moderate effect 
(25% impairment) on the students’ HRQoL was observed. Only three species were 
identified. The most prevalent was Malassezia furfur. Finally, no distinct clinical 
feature was linked with a specific species. 
Conclusion: PV has negative effect on the life of teens. Apart from climate, genetics 
and hyperhidrosis, its presentation could also be influenced by dandruff, routine 
application of petrolatum and socioeconomic status. Malassezia furfur is the main 
causative species of PV in Nigerian students. 
 
Keywords: pityriasis versicolor; Malassezia species; senior secondary school 
students; quality of life; tropical environment 
 
Word count: 25,791 
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      CHAPTER ONE 
INTRODUCTION 
1.1 Background  
Pityriasis versicolor (PV) is a superficial fungal infection of the skin. It is also known 
as tinea versicolor, previously as dermatomycosis furfuracea, tinea flava and 
achromia parasitica.(1) In Nigeria, the common names for PV include “eczema” in 
English language,(2) “Ifo” in Yoruba language, “Makenkero” in Hausa language and 
“Ngwo” in Ibo language; the three major languages spoken by Nigerians. 
It is a chronically recurring fungal infection despite the easy availability of antifungal 
medications; however, there are no guidelines acceptable for long term treatment. It 
is majorly asymptomatic but cosmetically not acceptable. Many affected individuals 
usually do not seek medical attention, thus its prevalence might be more than those 
inferred in the literature. PV occurrence is worldwide and covers most geographic 
locations. It is most prevalent in hot, humid climate(3) where it is seen all year round. 
In temperate regions, it is noticed more easily during summer when the skin tends to 
tan in light-coloured individuals. The disease affects males and females alike, most 
commonly young adults. 
It is non-contagious and highly prevalent in individuals with genetic predisposition, 
hyperhidrosis, poor general health, and immune-compromised states but not in 
pregnancy and diabetes mellitus.(3) The lesions are described characteristically as 
multiple hypopigmented and hyperpigmented macules; these may coalesce into 
large, irregular patches, and have a fine scaly appearance(4) which can become 
obvious by stretching the skin (Zeliri’s sign). Although the lesions may be 
asymptomatic, some patients complain of pruritus and tingling sensation. Meanwhile, 
in a majority of patients, the lesions are disfiguring, embarrassing and restrict choice 
of clothing. 
Malassezia species are the causative organisms of PV. They are lipophilic yeasts 
which are of the normal skin microflora. They convert from their saprophytic yeast 
form to the pathologic mycelial morphology to cause disease.(5) They are richly 
located in the sebum-rich body areas such as the face, chest, back and upper arm 
due to their requirement of lipid to grow.(6) Diagnosis of PV is essentially clinical. 
Examination with Wood’s light may reveal a yellowish or golden fluorescence. Direct 
microscopy of scales with potassium hydroxide shows hyphae and spores; the 
characteristic “spaghetti and meatballs” appearance. Culture of Malassezia requires 
a lipid rich media while molecular analysis as well as physiological characteristics 
can be used to identify the various species. 
There are various treatment options for PV which could be applied via topical and 
oral routes; however, relapse is common due to the importance of both exogenous 
and endogenous factors that aid the development of PV. 
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1.2      Literature review 
1.2.1 PV and climate 
Pityriasis versicolor (PV) occurs worldwide. However, its prevalence is influenced 
both by environmental and endogenous factors. An important environmental factor is 
the climate. PV affects more people living in the tropics than those in temperate 
regions. The tropical environment is rich in heat and moisture which are important 
elements that attribute to the development of PV.(7) 
In order to assess the effect of climate on the prevalence of PV; a quick literature 
search using “prevalence of PV” as the search object with focus on studies from 
various regions of the world was carried out. The regions were grouped according to 
the updated Köppen-Geiger climate classification by Peel et al.(8) which classified 
world climate into 5 types; namely type A – tropical, type B – arid, type C – 
temperate, type D – cold and type E – polar climate. This search, however, revealed 
only a handful of prevalence studies on PV. Selecting randomly 3 countries each 
from the same climate type showed the following: In tropical countries of Brazil, 
Central African Republic and Thailand; prevalence of PV were documented as 
13.2%,(9) 16.6%(10) and 17%,(11) respectively. In arid countries of Tunisia, Saudi 
Arabia and Libya, prevalence of PV were 21.6%,(12) 25.8%(13) and 27.8%,(14) 
respectively.  
In Malawi, a country in southern Africa with a subtropical climate type A, 8% of the 
people examined had extensive PV which the authors described as PV involving 3 or 
more regions of the body while 9% was the prevalence for mild disease among the 
people who were aged 15 - 24 years.(15) Also in the subtropical climate of Santo 
Andre in Brazil where the average all year high temperature is below 300 C, a 
prevalence of 3.1%(16) was documented. 
Available data from temperate climate are quite limited. In Italy a prevalence of 2.1% 
was observed in 1024 young sailors(17) while the famous study from Sweden by 
Hellgren et al. showed a prevalence of 0.5% in males and 0.3% in females.(18) 
There were no studies of PV documented in type E polar climate regions of the world 
such as Norway or Siberia. It is obvious from the above statistics that highest 
prevalence of PV is observed in arid countries, areas which have high temperatures 
all year round.  
1.2.2 PV and Age 
The common endogenous factors linked with PV include age, poor immune status 
and genetic predisposition. The age factor contributes significantly to the onset and 
duration of PV. The age distribution of individuals with PV in most epidemiological 
studies falls within the puberty period, 12 to 40years.(10, 11, 15, 19, 20) These are 
usually students and young adults. The high prevalence of PV in this age group is 
linked with the increased presence of androgen which stimulates sebum production. 
Also, the rise in the level of physical activity leading to increased sweating and the 
4 
 
probability of harbouring the causative yeast as part of skin flora is higher in this age 
group. However, studies assessing factors known to hasten or delay the age of 
onset of PV in these predisposed individuals are few. Apart from genetic 
predisposition (21), data is lacking on possible associated factors that may affect the 
age of onset of PV. Another research question yet to be adequately answered is with 
regards to the natural course of the infection. Although death has not been 
associated with PV, the degree of morbidity suffered by patients with PV as a result 
of chronicity and/or recurrence of the infection is unknown. Also are age and 
genetics the only factors that influence the course of PV? 
PV has rarely been reported in infants less than 2 years of age and in most of these 
cases the infants were premature and placed in intensive care following birth. In one 
report of PV in a 2-week-old infant; the authors suggest that the hot, humid 
environment of the incubator may have been a contributing factor,(22) although the 
sebum level was not assessed. Premature neonates are more often found to have 
the causative yeast on their skin, regardless of whether they develop PV lesions. 
These yeasts as part of their skin microbiota may have been picked up via 
nosocomial route because these infants are handled more frequently by health care 
personnel than babies born at term.(23) In an epidemiological study of PV in the 
pediatric age group by Jena et al.(24) conducted in Cuttack, a tropical region in India, 
PV in children aged up to 14 years accounted for about 31% of the total cases of PV 
seen in a 2-year period with about 4.8% cases presenting in infancy. This high 
prevalence may suggest that hot humid climate or environment increases the 
prevalence of PV in children and even infants.(24) 
Furthermore, it is unusual for elderly individuals to suffer from PV. This could be due 
to the reduction in sebum production that occurs with increasing age(25) although 
studies on PV in this age group is sparse. Similar to the prevalence of PV in the 
pediatric age group, environmental factors play a significant role in the prevalence of 
PV in the geriatric age group. Thus, the study by Di Silverio et al(26) showed the 
presence of Malassezia yeasts and hyphae in about 40.4% of hospitalized elderly 
patients aged over 60 years. They had the scaling and hyperpigmented patches of 
PV. The possible predisposing factors included heat and sweat, especially as their 
clothes were not changed frequently, and the frequency of bath taken may have 
been reduced in some cases.(26) There was no relationship observed between PV 
and underlying illness of these hospitalized patients, thus the presence of this skin 
disorder was not related to the immunocompromised state of the individuals. 
1.2.3 PV and skin hydration/sebum 
The combination of hydration and sebum contribute to the cause of PV by providing 
a conducive growth milieu for the etiological yeasts.(7) Studies measuring the 
difference in the stratum corneum humidity status and sebum excretion rate in PV 
lesions as compared with non-lesional skin or healthy individuals are quite limited. 
Investigation of the skin characteristics of PV patients as compared with healthy 
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controls using the non-invasive MPA-5 by Park et al. showed higher skin humidity, 
increased sebum excretion rate and increased trans-epidermal water loss (TEWL) 
values in PV patients(7). The authors deduced that higher humid status and sebum 
excretion of the skin form part of the factors that encouraged the growth of the 
etiological yeast of PV while the increase in TEWL is a consequence from skin 
barrier disruption caused by the interaction between the yeasts and skin barrier 
materials. They also noted no significant difference in these measured factors 
between the hypopigmented and hyperpigmented skin lesions. 
This result is in contrast with a study by Lee et al.(27) who observed reduced skin 
hydration status in lesional skin compared with adjacent infection-free skin. They 
argued that the reduced hydration level of the PV lesions was as a result of the 
alteration of the skin biophysical properties by the etiological yeasts on the body. The 
study unlike Park et al. did not measure the sebum excretion rate nor did they 
compare skin features of the affected individuals with healthy subjects. On the other 
hand, Burke’s study done many years(28) measured lipid levels in PV lesional skin 
and healthy skin (through a different methodology),  observed a higher skin lipid level 
in PV skin but this was not a consistent feature on all lesions. Meanwhile, Nazzaro-
Porro et al. observed higher levels of specific lipoperoxide values derived from the 
oxidation of different skin lipid classes in PV lesions than in normal controls and 
deduced that these lipoperoxides may play an important role in the pathogenesis of 
PV(29) particularly in hypopigmented PV lesions; this was confirmed by De Luca et 
al.(30) 
In neonates, sebum secretion by the skin is elevated due to maternally transferred 
androgen; this decreases significantly during childhood but starts to rise again during 
puberty and reaches its maximum in young adults.(25) Sebum production decreases 
in menopausal females but remains stable with increasing age in males.(25) The role 
of skin hydration and sebum production in PV is clear and the above studies have 
shown that this role may not be due to a combined effect; however, studies are 
needed to determine which of these two factors is more important and also the 
minimum level of sebum production and skin hydration at which PV is expected to 
develop. This could possibly influence the use or non-use of emollient in predisposed 
individuals. 
1.2.4 PV and immune status  
The relationship between the immune status and PV is not linear. For example, PV is 
not particularly more prevalent in patients with human immunodeficiency virus (HIV) 
and the clinical presentations also do not differ when compared with non-HIV 
patients.(31, 32) An individual with a low immune status does not necessarily 
develop the infection. The main factor predisposing an immunocompromised 
individual to PV remains unknown; probably genetics and hormone status driving 
sebum production play a determining role. Only a few studies of some diseases have 
shown a clear relationship between PV and a low immune state. An example is the 
6 
 
increased PV prevalence when compared to controls observed in renal transplant 
patients(33, 34) and chronic kidney disease patients;(35, 36) while the contrast is 
observed in diabetic patients in which case-control studies show a relatively low 
prevalence of PV.(37-39) Probably, the development of PV in chronic kidney disease 
patients may be related to the accumulation of or failure to excrete an unknown 
endogenous factor. It could also be due to a disruption in skin barrier mechanism or 
changes in the skin milieu. Since studies on hydration status of the stratum corneum 
in patients on dialysis revealed a low hydration state and increased TEWL which in 
one study correlated with the complaints of pruritus in these patients.(40, 41) Sebum 
excretion rate in these patients are yet to be documented in the literature. 
According to the minireview by Tragiannidis et al.(42) Malassezia yeasts, that is 
etiological agents of PV, found in immunocompromised patients such as diabetics, 
patients with haematological malignancies, bone marrow transplantation, and solid 
organ transplantation, Crohn’s disease and AIDS are known more often to cause 
severe skin conditions and systemic diseases. These severe skin conditions 
included Malassezia folliculitis, seborrheic dermatitis, catheter-related fungaemia and 
sepsis and a variety of deeply invasive infections.(42) PV was clearly not mentioned. 
This suggests the ability of these yeasts to invade the body to a deeper level when 
the individual is immunocompromised as compared to its very superficial state in PV. 
Meanwhile, PV infection is not dependent on the cellular or humoral immune status 
of the affected individual. Data from Saadatzadeh et al.(43) which assessed the cell-
mediated immune response to the active (mycelial) phase of Malassezia in PV 
patients as compared with age- and sex-matched controls revealed a similar immune 
response between the two study groups. There was no deficiency in cell-mediated 
immune response observed in the diseased patients. On the humoral immune 
response of PV patients compared with age- and sex-matched controls study 
conducted by Ashbee et al.(44) there was no statistically significant difference in 
measured total immunoglobulins produced in response to Malassezia furfur by both 
groups. The result of both studies supports the hypothesis that PV infection is not 
directly linked to the patient’s immune status.(43, 44)  
1.2.5.  PV and genetic predisposition 
PV is not a contagious disease and the lack of report of conjugal cases(23) among 
discordant couples who have been living together for a prolonged length of time 
combined with the tendency of PV to occur in at least one other member of the 
family unit lay credence to genetic predisposition being one of the important 
endogenous factors that contribute to the development of PV. Genetic models 
described by Hafez and later confirmed by He et al. revealed that PV patients fulfil 
the criteria for multifactorial (genetic-environmental) mode of inheritance.(21, 45) 
Meanwhile, inconsistencies with single-gene recessive or dominant mode of 
inheritance were shown as well as rejection of the environmental and non-
transmitted genetic models of inheritance.(21)  
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Available literature from various studies have revealed very strong positive family 
history of PV among patients, ranging from 21.1% to 38.3%(21, 45-47) families. He 
et al calculated the heritability of PV in first-degree relatives to be 48.13%, second-
degree to be 40.11% and third-degree to be 27.2%.(21) This shows a risk reduction 
with distance in family ties, thus justifying the multifactorial nature of the disease. 
Additionally, the role of environmental factor cannot be over-emphasized since the 
heritability of PV is by and large lower than 70%.(45) In general, these studies also 
agreed with the finding that patients with a positive family history of PV had an earlier 
onset and a longer duration of the disease. A chance of recurrence was also higher, 
compared with individuals without a family history. 
1.2.6 PV and other predisposing factors 
Other factors that may predispose individuals to PV include hyperhidrosis, use of 
oral contraceptives, malnutrition, pregnancy, skin occlusion and prolonged use of 
systemic corticosteroid. Evidence supporting the relationship between oral 
contraceptives use, malnutrition and PV is quite weak and not properly documented. 
Although hyperhidrosis is generally accepted as one of the predisposing factors to 
PV(23), studies have produced conflicting results. While profuse sweating was 
considered on the one hand, in the studies by Tarazooie and He et al. as one of the 
strong endogenous factors mediating the development of PV;(21, 48) on the other 
hand, this was not supported in the studies by Burke and Ingordo et al.(17, 49) were 
no significant association between PV and hyperhidrosis was observed. 
Even though the skin colonization by Malassezia yeasts is increased in the third 
trimester and postpartum period, the frequency of PV in pregnancy has been shown 
not to differ significantly from that of the general population.(50)  
PV studies in patients on prolonged steroid use are sparse. The incidence of PV in 
corticosteroid-treated patients as observed a long time ago by Boardman et al. was 
16%.(51) Similarly a significant relationship was observed by Burke(49) between 
increased systemic cortisol levels that are found in Cushing’s syndrome patients as 
well as those on systemic glucocorticoid therapy and PV development. The possible 
explanation for this interaction is not yet proven by research especially as this 
relationship with PV was not observed among patients applying topical 
glucocorticoids. An experimental work on steroids and Malassezia yeasts did not 
show any cause and effect relationship. Steroids did not encourage or increase the 
growth of the yeasts in culture. Moreover, topical glucocorticoids can induce a 
negative nitrogen balance and reduction in pH when applied on the skin.(49) This 
could in turn impede the growth of the fungi. 
Some studies could not relate personal hygiene with the development of pityriasis 
versicolor(46, 47) although this is in contrast to a general perception by most people 
that PV results from an inadequate personal grooming of the patients.(52) This 
perception could increase stress and feeling of being stigmatized in these patients. A 
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recent work on skin infections and infestations among Nigerian prison inmates 
showed that PV formed 27% of all 178 infections, second only to infections by 
dermatophytes.(53) Skin infection was significantly associated with the frequency of 
bath, frequency of soap usage and frequency at which their clothing was changed. 
These confirm a possible relationship between personal hygiene and skin infections 
and infestations of which PV was included. They also observed a significant 
influence caused by accommodation arrangements namely overcrowding and poor 
ventilation on skin infections. It would have been interesting to know if the prison 
environment (hot and humid) was considered also as a possible predisposing factor. 
Meanwhile, this study differs with a similar study of PV among Indian prisoners in 
which no significant difference in PV prevalence and clinical features was observed 
when compared with the general population.(54) 
1.2.7 Prevalence of pityriasis versicolor in Nigeria. 
Studies on PV in Nigeria are quite limited but documented prevalence of PV range 
from 6.7% in Northwestern region,(55) a region closest to the Sahara desert and 
higher temperatures all year round to 3.7%(56) in Southern region of the country 
which has a cooler climate and closest to the ocean. However, both studies had 
limitations. The first study was hospital-based which does not usually give a true 
prevalence of skin diseases in the community and the second was conducted in a 
primary school where majority of the pupils were below the adolescent age, the peak 
age of PV development.  
A prevalence of 4.6% was observed by Uneke et al. in an epidemiological survey of 
tinea capitis and PV infections among school children in South-east Nigeria.(57) 
While in the Southwestern region, a prevalence of 4.7% was observed, also among 
school children.(58) In both studies, an epidemiological comparison of PV was made 
with dermatophyte infections, in which the prevalence of dermatophytosis was 
significantly higher than PV (51.8% vs 4.6% and 15.2% vs 4.7%) while the children 
with PV were significantly older than those with tinea capitis. The peak age group for 
tinea was 3 - 7 years while for PV was 14 - 17 years.(57, 59)  
In neighbouring countries of Nigeria, few prevalent studies of PV have been 
conducted. Examples include Mali which is located to the north of the country. There 
Faye et al.(60) observed a group of children aged 15 years and below in rural 
communities of Mali for non-leprous hypochromic patches. A prevalence of 4.1% 
was documented, of which PV had the highest frequency of 39.4%. Studies from 
other West African countries like Ghana, Togo, Benin and Liberia could not be found 
in the literature. 
1.3  Aetiology of pityriasis versicolor 
PV is a superficial cutaneous infection caused by the fungus of the genus 
Malassezia, one of the numerous dimorphic fungi that infect humans and animals. 
This microorganism form part of the normal skin flora when it exists in the 
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saprophytic or yeast state. It causes PV most times when it changes to the hyphal or 
mycelial state; the mechanism by which this change of state is conducted has 
remained unclear.  
Meanwhile, epidemiological study of Malassezia yeast found on normal skin of 
individuals from tropical environment has shown increased chance of hyphal 
formation. This leads to the conclusion that the mycelial state of Malassezia per se 
may not always indicate the presence of a disease.(3) Another group argues the 
possibility of “overt” infection since these hyphae were isolated from non-lesional 
skin scales of same patients who had PV infection. Additionally, the percentage of 
hyphae isolated from skin of healthy individuals is negligible in comparison to 
samples obtained from PV lesions.(61) The reason why Malassezia yeasts have 
been implicated as aetiological agent of PV is the increased likelihood of obtaining a 
positive fungal culture from skin specimens taken from PV lesions than from clinically 
unaffected skin areas of either the same individual or matched healthy controls.(48, 
61, 62)  
1.3.1 History and taxonomy of Malassezia 
After several decades of continuous reclassification, Malassezia yeasts are presently 
placed in the Phylum Basidiomycota, subphylum Ustilaginomycotina, class 
Exobasidiomycetes, order Malasseziales and family Malasseziaceae.(61) There 
were disagreements as to when the organism was first grown, the optimal culture 
medium, the relationship between the different morphological and colonial variants of 
the organism, the genus to which it should be assigned and with what name, and the 
role it plays in a variety of cutaneous diseases. 
The pathological agent of PV was first described in 1846 by Eichstedt.(63) This 
fungus was later named Microsporum furfur by Robin Baillon in 1853, as he thought 
it was identical to the dermatophyte Microsporum auduoinii. In 1874, Malassez 
further described the shape (round, oval) and budding nature of this organism and 
differentiated it from dermatophytes. Robin Baillon in recognition of this work and the 
furfuraceous (consisting of or covered with flaky particles) nature of the PV lesions 
proposed the first nomenclature Malassezia furfur in 1889.(64) 
However, 15 years later Sabouraud described a group of budding yeast cells without 
hyphal elements observed in and isolated from normal skin and scalp. He proposed 
the genus Pityrosporum.(65) Thus two genera were established: Pityrosporum, as 
the yeast form found on normal skin flora and Malassezia as the mycelia form found 
in disease state.   
Panja in 1927 was able to successfully isolate the organism from PV lesions and he 
also suggested that both yeast and mycelia forms may be the different expression of 
one organism by proposing the merging of both genera into one.(64) This suggestion 
was not generally accepted as there were no scientific ways of proving that this 
relationship exists. Most important was the difficulty in culturing the organism in vitro. 
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The reason for the difficulty was later explained by Benham in 1939. She observed 
that the organism required a “fatty substance” to grow.(64) Once this lipid 
requirement was established it paved way for the formulation of various culture 
media that reliably recovered and maintained the organism thus enabling much work 
to be done on the taxonomy, physiology and biochemistry of these yeasts especially 
in the discovery of new species for each genus. 
By 1984 mycologists restricted the genus to just 2 valid species: a human one, M. 
furfur, and an animal one, M. pachydermatis. The old name Pityrosporum was 
rejected (nomen rejiciendum) because it was considered a synonym of Malassezia, 
a term already in use and so given priority according to the rules of taxonomic 
nomenclature.(66) 
Despite all these studies and more, the taxonomy and nomenclature of Malassezia 
species was marred with confusion and chaos until 1995 when the advancement in 
molecular techniques allowed physiological and ultrastructural studies describing the 
characteristics of each species. Using these techniques Guillot and Gueho analyzed 
104 different isolates of Malassezia, and subsequently defined seven species of 
Malassezia: M. furfur, M. sympodialis, M. obtusa, M. globosa, M. restricta, M. 
slooffiae, and M. pachydermatis.(67) In recent years, using the combination of 
biochemical, physiological, morphological and molecular techniques 7 additional 
species have been identified: M. dermatis, M. japonica (isolated from humans with 
atopic dermatitis), M. yamatoensis (in seborrheic dermatitis), M. equina, M. caprae, 
M. nana and finally M. cuniculi (last 4 isolated from various animals).(68)  
The current members of the genus Malassezia with their dates of identification as 
adapted from the review by Crespo-Erchiga et al.(66) are highlighted in Table 1.1 
below. 
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Table 1.1 Members of the Genus Malassezia and dates of identification(66) 
First Studies (3spp) 1996 Review (7spp) The Genus in 2014 (14spp) 
M. furfur 1889     
      P. ovale 1913  
      P. orbiculare 1951  
 
 
M. pachydermatis1935    
P. pachydermatis1925 
P. canis 1955 
 
 
M. sympodialis 1990 
M. furfur 1889  
M. pachydermatis 1935 
 M. sympodialis 1990  
 
M. globosa 1996 
M. obtusa 1996 
M. restricta 1996 
M. slooffiae 1996 
 
M. furfur 1889 
M. pachydermatis 1935 
M. sympodialis 1990 
M. globosa 1996  
M. obtusa 1996  
M. restricta 1996  
M. slooffiae 1996 
 
M. dermatis 2002 
M. japonica 2003 
M. nana 2004 
M. yamatoensis 2004 
 
M. caprae 2007 
M. equine 2007 
M. cuniculi 2010 
 
1.3.2 Other diseases associated with Malassezia 
PV is not the only mycosis caused by Malassezia yeasts. There are other diseases, 
both cutaneous and systemic, in which they have been implicated and a discussion 
on Malassezia and PV will not be complete without a brief mention of the role played 
by these yeasts in these diseases. In some, the association remains controversial 
and the pathogenesis unclear.  
The systemic infections caused by Malassezia include intravenous catheter induced 
fungemia, endocarditis, interstitial pneumonia and peritonitis in patients undergoing 
continuous ambulatory peritoneal dialysis.(61) Most of these systemic infections 
were said to be as a result of the fungus being introduced into the blood stream or 
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the peritoneum via the skin during these procedures. The rate of infection correlates 
with the length of time the catheters were kept in place. Malassezia can cause 
systemic infection in people of all ages particularly those with immunosuppression 
and venous catheter either central or peritoneal.(42) Affected individuals present with 
persistent fever, no response to antibiotics and a high degree of clinical suspicion is 
required for timely management.(61) 
For cutaneous diseases such as seborrheic dermatitis, pityriasis capitis and 
psoriasis, the role played by Malassezia is not completely clear. Controversial roles 
of Malassezia has been associated with also the following: neonatal cephalic 
pustulosis, atopic dermatitis, onychomycosis, sinusitis, confluent and reticulated 
papillomatosis of Gougerot-Carteaud and otitis externa.(61) 
Seborrheic dermatitis is a recurring disease commonly seen in sebum-rich areas of 
the skin, such as scalp, eyebrows, paranasal folds, upper chest and back. It is 
characterised by erythema and scaling.(61) It commonly affects neonates and 
infants, Parkinson’s disease patients and also immunocompromised individuals.(42) 
Current data available do not sufficiently define the pathological features of 
Malassezia that leads to the development and exacerbation of seborrheic dermatitis, 
but it has been considered as a deeper level of infection in comparison with PV(61). 
The yeasts were isolated from the dermatitis lesions by various studies (69, 70) and 
anti-fungal medications form part of the treatment plan for seborrheic dermatitis. 
Malassezia (Pityrosporum) folliculitis is a benign cutaneous disorder, characterised 
by follicular papules and subcorneal pustules most commonly located on the face, 
chest, back and upper arms. It is often pruritic and could be misdiagnosed as 
acne.(3) Direct microscopy of pustules usually reveals an abundance of Malassezia 
yeasts and the absence of other microorganisms. Histology is also helpful in 
diagnosis where a periodic acid-schiff (PAS) or methenamine silver staining 
technique will show the budding yeasts within the keratinous material of dilated hair 
follicles. A study in Korea showed a predominance of M. restricta in patients with 
Malassezia folliculitis.(71) 
Confluent and reticulate papillomatosis of Gougerot-Carteaud is a rare cutaneous 
disorder characterised by confluent, grayish-brown, hyperkeratotic papules often 
symmetrically located on the trunk.(3) It responds to topical and systemic anti-
fungals, although in combination with other modes of treatment. Studies on this skin 
disorder are few. However, M. furfur and M. sympodialis have been isolated from the 
lesions.(3) 
Neonatal cephalic pustulosis is a benign disorder commonly seen in neonates. It is 
characterised by non-follicular papulopustules found on the face and neck of 
newborns. Direct microscopy of the pustules have shown Malassezia yeasts, 
although the exact pathogenesis is not well known, this disease responds well to 
topical ketoconazole therapy.(61) 
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Pityriasis capitis (dandruff) also known as mild seborrheic dermatitis is a subclinical 
inflammatory condition of the scalp associated with episodic, recurrent or constant 
scaling of the scalp. It is more prevalent in young adults and may be aggravated by 
environmental factors such as dust, hair cosmetics, UV irradiation, and airborne 
irritants. Malassezia yeasts have been isolated from dandruff scalp(69) and the 
condition is known to improve on reducing the population of Malassezia on the scalp 
with proper antifungal treatment(72). Meanwhile, a study has demonstrated the 
contribution of other fungi apart from Malassezia such as Filobasidium and 
Acremonium species in the aetiopathogenesis of dandruff.(73) 
Atopic dermatitis (AD) is a chronic relapsing inflammatory skin disease characterised 
by severely itchy, red, dry, and crusted skin affecting all age groups but most 
commonly the paediatric age group. Pathogenetically, it results from a combination 
of defective skin barrier and inappropriate immune responses against both genetic 
and environmental factors. Malassezia yeasts exacerbate AD especially in those 
with dermatitis lesions involving mainly the head and neck regions.(61, 64, 74) 
These patients have been shown to have a higher IgE titre to Malassezia and also a 
more positive skin prick test to Malassezia allergen than healthy subjects.(64, 74, 75) 
M. furfur, M. globosa, M. restricta and M. sympodialis are the most common species 
isolated from atopic dermatitis skin lesions.(75, 76) Likewise, the addition of 
antifungals to patients’ management has resulted in rapid treatment response. In the 
interim, exact roles played by the fungi in atopic dermatitis remains under intense 
investigation. 
Psoriasis is a chronic inflammatory immune-mediated disorder that affects the skin 
and joints. The skin lesions are characterised by erythematous scaly papules and 
plaques. Although the aetiology of psoriasis remains elusive, Malassezia yeasts 
have been reported as one of the microorganisms that can exacerbate this disease 
condition. Some studies have isolated M. furfur, M. globosa, M. restricta and M. 
japonica from surfaces of psoriatic lesions.(77, 78) One of these studies was able to 
demonstrate pseudohyphae in active psoriatic lesions and none was observed in 
stable lesions.(77) The mechanism is still not clear since it is difficult to understand if 
the pseudohyphae developed as a result of the reduced barrier function and low 
immune defence observed in exacerbated lesions or if the presence of the yeasts 
contributed directly to the exacerbation. Nevertheless, these patients are known to 
respond more quickly when topical antifungals are included in their management.(78) 
Malassezia yeasts have been demonstrated to induce onychomycosis in normal and 
immunocompromised patients.(79, 80) This association remains contentious 
especially as these lipophilic yeasts are known not to normally colonize nails and 
besides nails are poor sources of lipids. Also these yeasts do not have keratolytic 
properties as dermatophytes. Zhao et al. attributed the process whereby Malassezia 
can cause onychomycosis to a change in the microenvironment induced by the local 
application of steroids.(79) 
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1.4 Pathogenesis of pityriasis versicolor 
The pathogenesis of PV is yet to be completely explained. However, various studies 
on PV development concur on the interdependence of the following factors: 
Malassezia skin colonization, sebum production and individual predisposition. PV 
infection is caused by the lipophilic dimorphic yeasts named Malassezia. These 
yeasts colonize the stratum corneum (SC) and are among the organisms that make 
up the skin microbiota.(1, 72) The microorganisms of the skin flora are quite diverse 
and are made up of bacteria, viruses, protozoa and fungi. Some are transient that is 
they are detected as a result of transient hand/body carriage from contamination or 
transmission events (examples include adenovirus and rotavirus) while others are 
resident. The resident flora are persistent and cannot be completely washed away; 
examples of these group of organisms include Malassezia, Staphylococcus 
epidermidis, Corynebacterium, Demodex folliculorum, just to mention a few.(81) 
The skin becomes colonized by microbes soon after birth. These microbes are 
usually from the environment and they subsequently interact with the epithelial cells 
of the newborn leading to microbial colonization and co-existence.(82) Most of these 
microbes are beneficial, commensals or neutral, however, a few do become 
pathogenic and harmful to the skin or body in general.(82) The commensal or 
pathogenic nature of an organism is argued to depend on the immune system of the 
individual rather than the inherent properties of the microbe.(82) Of equal importance 
is the interaction among species. In order to survive, a microbe has to compete with 
other microbes of the normal flora for available nutritional elements and space. By so 
doing, they try to keep the skin flora in a stable state and resist abrupt changes in the 
community structures. This process in the long run also protect against the growth of 
pathogenic microbes that may cause disease.(81, 82)   
Various skin structures may harbor their own type of microbes. Such that the stratum 
corneum, keratinocytes, hair shaft and follicle, sweat glands, apocrine glands and 
sebaceous glands may each have their own type of unique microorganisms which 
colonize there. Malassezia yeasts reside mainly in the stratum corneum, though 
some authors suspect their presence in the hair follicles which could act as a 
reservoir and thus accounts for the recurrence of PV after treatment.(47, 73) 
Meanwhile, the stratum corneum provides nutrients in form of lipids secreted by the 
sebaceous glands. Sebum production is increased in humans at puberty and so is 
PV. This also explains the reason for the predilection of the yeasts for sebum-rich 
regions of the body. Sebum lipids are postulated as essential ingredients that 
support the growth of these yeasts while the sebum triglycerides are degraded by 
Malassezia-derived lipases to produce proinflammatory unsaturated fatty acids, an 
antimicrobial property that limits the types of microorganisms that can co-exist on the 
skin.(83)  
Since these Malassezia yeasts exist as skin flora on healthy skin, the development 
of PV in certain individuals indicates an interactive role played by other factors which 
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could have altered the ecosystem of the skin, and thus a resultant change in the 
yeasts’ microbial state. This interactive process was well described in the conceptual 
framework developed by Rosenthal et al.(82) Most important of these factors that 
could predispose individuals to develop PV is the presence of high temperature and 
high relative humidity. There are also behavioral characteristics of the individual such 
as cosmetic use and host demographic characteristics such as seborrhea and 
hyperhidrosis. Of equal importance is the genetic susceptibility of the individual.(21) 
All of these driving factors interact to some degree to influence the pathogenesis of 
PV. 
Although PV is a cutaneous infection, it is associated with little or no inflammation 
unlike other Malassezia-associated diseases such as Malassezia folliculitis and 
seborrheic dermatitis. Malassezia are dimorphic yeasts, that is, they are able to exist 
in both yeast and mycelial (hyphal) forms. The mechanism by which individual’s 
endogenous as well as environmental factors influence the yeasts to convert to the 
hyphal state, thus causing PV is also not well established. Moreover, studies 
investigating the absence of an active immune response by the host to the presence 
of Malassezia and possible factors that mediate the immune balance in the host 
between the commensal and pathogenic state of the yeasts are lacking in the 
literature. A more likely hypothesis has been linked to the lipophilic nature of the 
yeasts cell wall. Lipids reduce phagocytosis of Malassezia by neutrophils. 
Phagocytosis is an important nonspecific immune mechanism for removal of 
microorganisms from the body. The uptake of the yeasts by these inflammatory cells 
is efficiently higher when they are killed than when they are alive.(64)  
Presently there is little information on the relative pathogenicity or virulence factors of 
Malassezia species. The limitation by the body’s neutrophils in killing the organism 
may account for its persistence in predisposed individuals. A study described by 
Ashbee and Evans(64) specified that only 5% of the Malassezia cells taken up by 
neutrophils were actually killed in an in vitro complement-dependent process, and 
this killing ability by the same neutrophils was increased to 23% when the yeasts 
were pretreated with ketoconazole. This was in contrast with the killing of 30% - 50% 
Candida albicans yeast cells and 80% of the cells of other fungal genera. Another 
hypothesis proposed for this limitation was attributed to the production of azelaic acid 
by Malassezia when it is grown in the presence of oleic acid or olive oil. Azelaic acid 
scavenges oxygen radicals, thus preventing oxidative killing of the organism by the 
phagocytes.  Likewise is the protective function of lipids richly found within the cell 
wall of the organism; this reduces their uptake by and subsequent activation of 
neutrophils and so protecting them from being phagocytosed.(64) M. furfur produces 
pityriarubins which is protective against neutrophilic activity. The lack of inflammation 
seen in PV has been attributed to pityriarubin through its role in down regulation of 
the immune response.(84)  
Immunomodulatory properties of Malassezia have been demonstrated in mice and in 
vitro. In mice, Malassezia through the up-regulation of macrophages protect against 
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infection and malignancy(85) while in vitro it reduces the production of cytokines 
such as interleukin 1, interleukin 6 and tumour necrosis factor-alpha.(86) Cellular 
and humoral immune reactions to Malassezia have been measured in healthy 
individuals despite their having no evidence of Malassezia-associated diseases; 
these activities were age-related with higher levels observed in young adults and 
lower levels in children and the elderly.(43, 44, 87) This poses some difficulties in 
studies on the immune pathogenesis of Malassezia-associated disorders and it will 
be necessary to conduct these studies as age- and sex-matched case-control 
studies in order to appropriately interpret the results. Meanwhile studies have not 
shown any deficiency in cell-mediated immunity to Malassezia in patients with 
PV.(43, 64) 
1.4.1 Stratum corneum (SC) and PV 
The human skin is made of the epidermal, dermal and subcutaneous layers. The 
stratum corneum (SC) is the final differentiated product of the epidermis.(88) In its 
healthy state, the SC forms a protective barrier against various environmental insults 
including pathogenic microbes, damaging irradiation, and potentially toxic 
xenobiotics and it also maintains skin/body hydration by preventing water loss.(83, 
88) A disruption of the skin barrier structure and function has been observed in 
PV.(27) These disruptions include an increase in transepidermal water loss (TEWL) 
and a significant reduction in skin hydration. The resultant effect of these disruption 
processes leads probably to the pathologically increased fragility of PV lesional skin 
surface.(61)This can be demonstrated in the “evoked-scale” sign(61) also called 
“Zeliri’s sign”(89). This sign is elicited when on stretching or scraping the surface of a 
PV lesion, scales become more visible. The precise pathogenetic mechanism by 
which Malassezia contributes to this characteristic feature of PV has several 
explanations. Some hypotheses are discussed below.  
The SC is the most superficial layer of the skin that is solely responsible for the 
characteristic features of PV which is scaling and dyspigmentation. To fully 
understand the pathogenesis of PV, it is important to understand the structure and 
organization of the SC and how these properties are altered during PV. The SC is a 
multilayered tissue composed of anucleated, flattened cells which are surrounded by 
multiple lamellar sheets of lipids.(83) It has also been described as a “unique 
sophisticated biosensor” that signals the underlying epidermis to respond to external 
stresses.(90) SC has been likened, in the simplest terms, to a brick wall (these are 
the terminally differentiated keratinocytes also called corneocytes) linked by 
intercellular cement (this is composed of a continuous matrix of specialized 
lipids).(90) The corneocytes provide protection against injuries while the 
intercorneocyte lipids which are mainly broad sheets of ceramides produced from 
lamellar bodies in the granular layer, serve as water barrier.(88) SC is formed during 
the process of keratinization of which the final act is desquamation. This is the 
orderly release of single corneocytes at the skin surface. Desquamation is facilitated 
by several proteolytic enzymes that degrade corneodesmosomes which are the 
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protein structures that fasten neighboring corneocytes together both in the plane of 
the SC layer and adjacent layers.(90) These proteolytic enzymes are controlled in 
the end by water activity and the pH of the SC.(83) Another possible facilitator of the 
desquamation process is sebum. The presence of triglycerides and short-chain fatty 
acids, as structural barrier lipids of the SC may disrupt the organization in the 
superficial layer of the intercellular lipid (intercellular cement).(83) Triglycerides and 
short-chain fatty acids are produced and released primarily by the sebaceous gland. 
Desquamation process can be facilitated by the presence of yeasts in the SC. Three 
distinct forms of Malassezia yeasts were recognized in the SC by Piérard et al.(91) 
These include round spores or conidia, budding spores and mycelium. Meanwhile, 
the mycelial elements are regularly observed to be located within the corneocytes. 
They are usually the invasive form of most yeast. Additionally, the keratinous content 
(mainly the tonofilaments) of these yeasts invaded cells are replaced by “amorphous, 
moderately electron-dense material” which were observed by Borgers et al.(92) as 
lipid in nature. Similar amorphous material was observed in between keratinocytes 
(extracellular compartment); most often in form of several sized spheres. Its 
keratinocyte origin is supported by the certainty of frequent membrane ruptures of 
swollen invaded keratinocytes. The degradation of the tonofilaments in the 
keratinocytes is speculated to be via the activity of Malassezia yeast enzymes. The 
replacement by lipids serve as nutritive material, which were demonstrated to be 
essential for growth initiation and maintenance of this lipophilic yeast in the SC.(92) 
Meanwhile this work done by Borgers et al. is yet to be confirmed as a similar study 
by del Palacio-Hernanz et al.(93) who studied the ultrastructure of PV lesions before 
and after treatment with cyclopiroxolamine could not observe these intracellular 
amorphous materials but rather severe necrosis of the cytoplasm. The reason was 
attributed possibly to the short fixation time by the later authors (2 weeks vs 2-3 
days).  
In conclusion, although the exact structural alterations of the SC are still unknown, 
the possible combination of frequent membrane ruptures of invaded keratinocytes 
and the activities of the Malassezia yeasts enzymes may contribute to the increased 
fragility of the lesional SC which is evident in the “Zeliri’s sign” or “evoked-scale” sign 
of PV. 
1.4.2 Mechanism for hypo- and hyperpigmentation of PV lesion 
Some studies have been done to explain the reason why PV lesions are either 
hypopigmented or hyperpigmented. Some have tried to answer this question by 
observing the relationship between Malassezia and melanocytes. Study by Karaoui 
et al.(94) confirmed earlier research in which no difference in number of melanocytes 
between PV skin whether hypopigmented or hyperpigmented and normal skin was 
found; but rather observed a difference in the dispersion and arrangement of 
melanosomes by the melanocytes.  
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In hypopigmented skin, the melanosomes were individually dispersed and fewer in 
number while in hyperpigmented skin, they were sequestered in most cells.(94) This 
was later collaborated by Galadari et al.(95) but refuted by Dotz et al.(96) who 
examined biopsy specimens from lesions of hyperpigmented PV involving a 
vitiliginous skin and found absence of both melanosomes and melanocytes. This 
study increased the doubt of a possible role play by melanocytes in the 
dyspigmentation of PV lesions.  
The explanation behind the interaction between Malassezia causing PV and 
melanocytes was further attempted by Krämer et al.(97) who suggests an indole 
alkaloid produced by M. furfur from tryptophan called melassezin as the likely cause 
of the hypopigmented lesions. Melassezin induces melanocytes to undergo 
apoptosis and thus reduces melanin production but this may not explain the 
hyperpigmentation of PV lesions. Other reasons for the hypopigmentation of some 
PV lesions have been connected to the production of lipoperoxides from oxidation of 
skin lipid by the yeast. Since a higher lipoxygenase and lipoperoxidase activity was 
measured in hypopigmented lesions positive for fungal hyphae and spores than 
controls.(29, 30) 
Another speculation in view of the hypopigmentation of PV lesion worthy of note to 
mention is the role of the lipid-like material produced by the Malassezia yeast in the 
stratum corneum. The hypochromia is said to be as a result of filtering of the 
ultraviolent light provided by the “lipid” screen.(92) This “lipidification” of the SC is 
clearly documented only with Malassezia yeast infection and thus differentiates it 
from other fungal infections.  Also this lipid process is not influenced by antifungal 
medications such as itraconazole. For this reason the hypopigmentation of PV 
lesions persists for 3 – 4 weeks after disappearance of viable fungi from the skin 
since normal epidermal regeneration takes about 4 weeks.(92)  
Meanwhile, another school of thought has attributed the color change of PV to the 
thickness of the stratum corneum. In both pigmentary states, the thickness of the 
stratum corneum differs with hyperpigmented skin being thicker than hypopigmented 
skin and both being thicker than that of uninvolved skin.(94) 
1.4.3 Histology of PV lesions 
Electron microscopy of skin scales from PV lesions has revealed the clustering of 
yeast cells and short hyphae in nest-like cavities.(98) The hyphae may be seen 
perforating the outer layer of the stratum corneum perpendicularly.(93) Malassezia 
species reproduce asexually by monopolar, enteroblastic budding from a 
characteristic broad or narrow base depending on the species. Separation leaves a 
prominent bud scar through which successive daughter cells emerge.(64) In lesional 
skin, particularly around hair follicles and acrosyringium, the clustering of yeast cells 
and mycelial hyphae is larger in the superficial part of the stratum corneum than 
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deeper layers. Furthermore in healthy skin, the clusters are mainly made up of yeast 
cells and are fewer in number (98, 99). 
Histology of skin biopsy from PV patients can be accessed via the Hematoxylin-
eosin stain or the PAS stain. Basically, the histology has shown a slight to moderate 
hyperkeratosis with “basket weave” stratum corneum, acanthosis, and vacuolization 
of epidermal cells.(99) There is also increased or normal basal layer pigmentation. 
Occasionally, melanin incontinence may be seen.(61) Gaitanis et al.(61) describe 
two types of PV that may be observed histopathologically from lesional skin biopsy; 
these are the inflammatory and non-inflammatory PV. The non-inflammatory PV is 
characterized by mild or almost absent infiltration of the dermis by superficial 
perivascular inflammatory cells while in the inflammatory PV, there is a moderately 
dense infiltration in the upper dermis of perivascular inflammatory cells. These 
mononuclear infiltrates are characteristically Langerhans cells, T lymphocytes and 
occasionally plasma cells.(95) Meanwhile, numerous budding yeast cells and short 
hyphae can be viewed in the stratum corneum and only the hyphal and not the spore 
form of the yeast are observed within the cells.(1) Unusual histological features 
include the presence of dilated blood vessels in relation to the extremely rare 
erythematous PV and papillomatosis like acanthosis nigricans.(99) 
1.4.4 Malassezia and healthy skin 
The presence of Malassezia yeasts on healthy skin of humans was described since 
the second half of the 19th century, and it soon became evident that colonization 
density was associated with age and differences in the activity of sebaceous glands 
in different areas of the body. However, there are no differences observed between 
the Malassezia species identified from healthy and diseased skin.(74) 
Malassezia, as part of the body flora can be isolated from the sebum-rich areas of 
the skin, particularly the chest, back, and head regions. A study done by Leeming(6) 
examined clinically normal skin at 20 different sites over the entire body surface. 
Malassezia species were recovered from every subject from the chest, midline back, 
scalp, ear, and upper inner thigh. The highest mean population densities occurred on 
the chest, ear, upper back, forehead, and cheeks. Some differences in carriage rates 
were noted between females and males, with higher population densities from the 
lower trunk and upper thigh of males. 
In a study by Lim et al. on the distribution of the different Malassezia species on 
normal human skin,(100) M. restricta was seen to predominate on the scalp, M. 
sympodialis on the trunk and M. globosa was widely and equally distributed in all 
seborrheic areas. When the number of colonies isolated from healthy individuals was 
compared with those from PV, seborrheic dermatitis, AD and psoriasis patients; the 
number was comparable with PV patients but significantly smaller in seborrheic 
dermatitis, AD and psoriasis.(72, 74) 
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1.4.5 Malassezia in animals 
Malassezia is rarely isolated from the environment because it is mostly confined to 
the skin of warm blooded animals. This is probably because its distribution in nature 
has not been well researched. 
Veterinarians’ investigation of these yeasts on the skin of several animals 
demonstrates the role of M. pachydermatis (and to a lesser extent, M. furfur, M. 
obtusa, and M. sympodialis) as the causative agents of otitis externa in cats and 
dogs. M. pachydermatis is also known to cause Malassezia dermatitis in dogs. This 
chronic skin disorder with similar clinical features to seborrheic dermatitis in humans 
is characterized by relatively demarcated scaly erythematous patches located at the 
sebum-rich regions of the animal.(101) Other clinical features that could be 
associated with Malassezia dermatitis in animals include pruritus, lichenification, 
excoriations and alopecia. 
Meanwhile, studies in many other animals have shown that specific species of 
Malassezia, just as in humans, also form parts of their skin microbiota. Such that M. 
equine is commonly isolated from the skin of monkeys, pigs, bears, birds, and 
horses. M. caprae specifically colonises goats while M. nana colonises cattle and 
cats.(66) The most recent addition to Malassezia species, M. cuniculi was isolated 
from rabbits.(68) 
1.4.6 Predominant Malassezia species in PV  
The predominant causative Malassezia species of PV have been demonstrated from 
different countries. Studies in Spain by Crespo Erchiga et al.(102) were the first to 
show M. globosa as the most prevalent species in PV lesions. M. globosa was also 
the most prevalent species observed in Japan by Nakabayashi et al.(70) in Spain by 
Aspiroz et al.(103) and in India by Dutta et al.(104) Also in Iran by Tarazooie et al.(48) 
and Bosnia-Herzegovina by Prohic et al.(105) In particular, Aspiroz et al.(103) 
demonstrated greater lipase and esterase production in M. globosa strains than in 
other species of the genus, a fact that may explain the greater level of pathogenicity 
associated with this species on human skin, and may also support its hypothetical 
role in the etiology of PV. However, contrasting results were obtained in Canada by 
Gupta et al. where a predominance of M. sympodalis was observed although noted 
is the important difference in culture medium and methodology used when compared 
with aforementioned authors.(3) Other countries where M. sympodialis was observed 
to predominate in PV lesions include Brazil(106, 107) and Argentina.(20)  
It is also noteworthy to state that some PV studies conducted in tropical or 
subtropical climates regions have shown a clear predominance of M. furfur. 
Examples are studies in Madagascar, Panama, Brazil and later Indonesia by 
Kristanty et al.(108) These results may confirm the over eighty-year-old hypothesis 
which postulates that differences in species of Malassezia which infect different 
individuals are based on distinct geographic distribution. 
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1.5 Clinical features of pityriasis versicolor 
PV lesions are characterised by discrete confluent, scaly, dyspigmented, irregular 
macules.(3) These lesions may be hypopigmented or hyperpigmented and an 
individual may have both types of lesions. The hyperpigmented lesions vary in colour 
from pink or tan to dark brown or black.(4)  
The distribution of the lesions generally parallels the density of sebaceous glands 
and common sites of affectation include the chest, face and back; flexural 
involvement of PV is rare.(7, 46) Morphologically the common patterns of PV lesions 
could be macular with dyspigmented areas, follicular which is usually multiple 
hypopigmented macules surrounding hair follicles, confluent which are composed of 
multiple macules arranged very close together and in an irregular pattern and finally 
the macules could be tear-drop like which is known as the guttate pattern.(47) 
In literature, unusual and rare forms PV lesions have also been described. These 
include: 
a. Inverse tinea versicolor(5) in which the characteristic PV lesions are mainly 
located in the axillae, groin or perineum. Differential diagnosis of this form of 
PV will include dermatophyte infections, erythrasma and seborrheic dermatitis. 
b. Pityriasis versicolor atrophicans in which the lesions are atrophic, 
erythematous and asymptomatic. Some lesions may have minute surface 
teleangiectasia. The topography of PV atrophicans generally follows that of 
common PV and it partially or completely resolves with appropriate antifungal 
therapy. The possible differential diagnosis of this form of PV includes 
anetoderma, acne scars, and macular atrophy. Histology is required to make 
diagnosis.(109) 
c. Pityriasis versicolor pseudoatrophicans in which the typical hypo- and 
hyperpigmented PV lesions coexist with atrophic patches. These atrophic 
patches are iatrogenic and secondary to prolong topical corticosteroid therapy. 
The lesions resolve with the suspension of the steroid use.(109) 
d. Blaschkoid pityriasis versicolor(110) was described as a rare variant in which 
the PV lesions are distributed along Blaschko’s lines. 
e. Pityriasis versicolor rubra is a red variant of PV in which the lesions are 
erythematous and has overlying teleangiectasia which can be seen through a 
capillaroscopy. Lesions are distributed in sebum-rich body areas and improve 
with antifungal treatment.(111) 
1.6 Differential diagnosis of pityriasis versicolor 
Pityriasis versicolor is relatively easy to diagnose especially in dark skinned 
individuals although the varying clinical presentation of the lesions may be confusing 
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to an inexperienced physician.(4) Possible differential diagnosis of PV will include 
pigmentary disorders such as vitiligo, idiopathic guttate hypomelanosis and melasma; 
scaling is usually absent in these disorders. Other diseases to exclude are pityriasis 
alba, Hansen’s disease, pityriasis rosea, pityriasis rotunda, hypo- or hyperpigmented 
mycosis fungoides, secondary syphilis, lentigo solaris, piebaldism and post-
inflammatory hyperpigmentation.(23) Pityriasis rotunda is a rare disorder of 
keratinization characterized by a persistent, hyperpigmented or hypopigmented, 
geometrically perfect circular patches of dry ichthyosiform scaling with no 
inflammatory changes.(112) Pityriasis rotunda lesions may be associated with 
malignancies and liver diseases and it can be misdiagnosed as PV. In addition, 
some of the diseases also caused by Malassezia such as seborrheic dermatitis and 
confluent and reticulated papillomatosis of Gourgerot and Carteaud may co-exist and 
or resemble PV; thus making diagnosis more difficult.(70)  
1.7 Diagnostic investigations in PV management 
1.7.1  Direct examination 
On direct examination of the lesions, Zeliri’s sign may be elicited. The sign is positive 
if stretching of the skin reveals the fine desquamation of the lesions. This is due to 
the slight collapse of the keratin.(89) However, this sign has a low efficacy in clinical 
diagnosis with high false negative results.(89) 
Wood’s light examination may also help in the diagnosis of PV. Wood’s light is 
produced with a high pressure mercury lamp emitting radiation between 320nm and 
400nm (ultraviolet A). It is absorbed by melanin and it produces characteristic 
fluorescence in pathologic conditions, thus making it a useful diagnostic tool in 
pigmentary and some cutaneous disorders. The examination should be conducted in 
a dark environment so the fluorescence can be well appreciated. The fluorescence 
of PV lesions tends to be bright yellow or golden yellow.(23) A positive response has 
been observed in only about a third of cases.(113) This examination does not 
confirm PV diagnosis.(26) 
Most recently added is a possible bedside test in the PV diagnosis called “in vivo 
gram staining of tinea versicolor”.(114) The technique involves the use of gentian 
violet to stain PV lesions. PV is present when the infected area becomes more 
prominent on cleaning off the stain with alcohol. This effect has not been observed in 
other pigmenting disorders. It was noticed that gentian violet forms a covalent bond 
with thioredoxin reductase 2 which is produced by Malassezia. The accentuation 
could also be due to alteration in either the host or fungal lipids by the stain.(114) A 
validation study is needed to assess the level of efficacy of this method. 
1.7.2 Microscopic evaluation 
Microscopy of the PV scales adds a distinguishing feature to its diagnosis and helps 
differentiate it from the various skin disorders that may have similar clinical features 
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to PV. The scales for light microscopy are usually taken from the centre of lesions, 
where a large number of the yeasts are expected to be obtained.(113) Skin scraping 
may be collected directly onto a glass slide with a blade or the edge of a second 
glass slide.  
Alternatively, a scotch tape stripping technique can be used.(76) The tape is placed 
on a glass slide and examined under the microscope. The keratin and debris of the 
skin scales are first dissolved with the use of 10-20% potassium hydroxide and then 
stained with methylene blue, parker ink or lacto-phenol blue to encourage clear 
viewing of the fungal element.(102) The characteristic “spaghetti and meat balls” 
appearance of the fungus is usually observed.  
1.7.3 Culture characteristics 
Malassezia is lipophilic and requires lipid medium to grow in vitro; cultures have to 
be grown on selective media, except for M pachydermatis which can also grow on 
standard media (Sabouraud dextrose).(102, 115) The 2 media commonly used to 
isolate Malassezia are modified Dixon agar (mDixon agar), first described by Van 
Abbe in 1964 and LN medium described by Leeming and Notman in 1987.(68)  
Modified Dixon Agar medium comprises 36 g malt extract, 10 g bacteriological 
peptone, 20 g desiccated ox bile, 10 ml Tween 40, 2 ml glycerol, 2 g oleic acid, 0.5 g 
chloramphenicol and 0.5 g cycloheximide(116) while the LN medium comprises 10 g 
bacteriological peptone, 0.1 g yeast extract, 5 g glucose, 8 g desiccated ox bile, 1 ml 
glycerol, 0.5 g glycerol monostearate, 0.5 g Tween 60, 10 ml whole fat cow milk, 0.5 
g chloramphenicol and 0.5 g cycloheximide.(68) These are added in 1 L of 
demineralized water. The pH is adjusted to 6.0 and 12 - 15 g of agar is added before 
the mixture is sterilized by autoclaving at 1150 C for 15 min, and aliquot as required. 
Other media used in the culture of Malassezia include Sabouraud agar plus olive oil, 
CHROM agar(117).  Growth of the yeast on these agars is observed on an average 
of 5-10 days. The mDixon medium permits better visualization and isolation of the 
colonies, which is very important when, as is common, 2 or more species are found 
in the same lesion(118). Incubation temperature is also an important factor, since 
several species (among them M. globosa and M. restricta) do not grow above 36o C. 
Thus, cultures should be incubated in ovens between 30o C and 35o C, and the 
dishes wrapped in plastic bags to ensure suitable humidity and prevent the medium 
from drying out.(63) The yeast form of the fungus predominates in culture though 
hyphae may also be seen. 
The morphology of the grown colony varies according to the species of Malassezia. 
Its surface could be dull or glistening, smooth or rough, convex or flat with slightly 
folded or grooved edges. Texture could be friable, coarse or hard. The colour varies 
from cream to white. Sometimes a slight central elevation could be visualized. 
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Microscopy of the cultured yeasts that is a colony also varies with species. The cells 
are usually unipolar in appearance with a broad or narrow base bud. The cells could 
be large or small, spherical or cylindrical, ovoid or globose. These variable 
macroscopic and microscopic features have been implored in the identification of the 
different species of the organism. 
1.7.4 Biochemical tests 
These are usually carried out on the cultured specimen and not directly on the scales. 
1. Catalase reaction: A positive reaction is seen when there is production of 
gas bubbles on adding a drop of hydrogen peroxide on a tiny part of the 
cultured specimen. Only M. restricta gives a negative reaction. 
2. Tween assimilation test:  Malassezia species grow differently around 
Tween compounds, basically Tween 20, 40, 60 and 80. 
3. Esculin Test: The splitting of Esculin reveals the presence of β-
glucosidase activity of Malassezia species. This is positive with M. furfur, 
M. sloofiae and M. sympodialis. 
4. Assimilation of glycine: This is positive in M. furfur only. 
1.8 Identification of Malassezia species 
The Malassezia species can be identified based on their macroscopic/microscopic 
features, and physiological characteristics and also the use of molecular techniques. 
The macroscopic features of the predominant colonies include the shape, size, 
colour, texture, and the characteristics of the medium around them. While the 
microscopic features of the cultured yeast after staining include the morphology, size 
and nature of the budding base. To assess physiological properties of Malassezia 
species; catalase and β-glucosidase reactions (esculin test), and Tween test using 
10%, 0.5%, 0.5% and 0.1% of Tween 20, 40, 60, and 80, respectively, are done. 
This method is usually time-consuming, though it is cheap and does not require 
sophisticated equipment. 
1.8.1 Morphological and physiological identification methods 
The macro-/microscopic characteristics as well as the physiological features of some 
Malassezia species as described by Gueho et al(63) are summarized below: 
Table 1.2. Morphological characteristics of Malassezia species 
Species  Nature of colony Microscopy  
M. furfur Dull, smooth or slightly folded 
with convex elevations (average 
Large, oval, cylindrical or 
spherical cells, broad base 
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diameter 5mm); soft/friable 
texture 
bud 
M. pachydermatis    Dull, convex sometimes 
umbonate, cream in colour 
(average diameter 5mm); 
soft/friable texture 
Small ovoid cells, broad 
base bud leaving a 
prominent budding scar 
M. sympodialis Glistening smooth, flat or with 
slight central elevation (average 
diameter 5mm); soft texture 
Ovoid to globose cells, 
narrow base bud. Repetitive 
or sympodial budding occur. 
M. globosa Raised, folded and rough 
(average diameter 4mm); 
coarse and brittle texture 
Spherical cells, narrow base 
bud 
M obtuse Smooth and flat (average 
diameter 4mm); sticky texture 
Large cylindrical cells 
M restricta Dull surface; smooth to rough 
edges (average diameter 3mm); 
hard and brittle texture 
Spherical or oval cells, 
narrow base bud  
M slooffiae Rough surface with fine grooves 
(average diameter 3mm); 
coarse texture 
Short cylindrical cells with 
buds formed on a broad 
base. 
 
Table 1.3. Physiological features of Malassezia species 
Species 
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M. 
pachydermatis 
+ + + + + + + + ± + 
M. sympodialis _ + +  + _ + + + + 
M. globosa _ + ±  _ _ _ _ _ + 
M. dermatis _ + +  + + + + _ + 
Growth on 
mDixon at 
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M. furfur _ + +  + + + + _ + 
M. slooffiae _ + +  + ± + _ _ + 
M. obtusa _ + ±  _ _ _ _ + + 
M. restricta _ + +  _ _ _ _ _ _ 
M. japonica _ + +  _ _ + _ + + 
 
mDixon (modified Dixon agar); Tw (Tween); +, positive; _, negative; ±, weakly 
positive; SDA (Sabouraud dextrose agar). 
1.8.2 Molecular identification methods 
Molecular techniques in Malassezia species identification was developed in the mid-
1990s particularly the rRNA sequencing analysis. This has accelerated 
investigations into Malassezia epidemiology and pathobiology. It also encouraged 
research on the association of Malassezia species with regard to specific geographic 
locations(4). The probe used in these techniques to identify Malassezia could be 
culture and non-culture based that is, samples can be collected from skin and 
cultured before performing the molecular analysis or the analysis can be done 
directly from patient skin scales.(119) The difference is that the yeast yield when 
done directly may be insufficient for the molecular analysis while the drawback for 
the culture based analysis is the possibility of missing out some species especially 
slow growing species or those that are outgrown in culture by contaminating fungi. 
The four molecular techniques already in use to detect and identify Malassezia 
species include:  
1. DNA sequence analysis. This is first method implored in Malassezia 
species identification. It involves the nucleotide sequence analysis of the 
obtained ribosomal DNA gene of the yeast and the result is 
phylogenetically compared with distant or closely related species. 
2. Biotyping using Api 20 NE and ApiZym enzymes. This has received very 
little attention(120) and has so far being used to identify six of the 14 
species of Malassezia. It includes the use of enzyme activity profiles of the 
different species. Common enzymes studied include catalase, esculin, 
lipase, phospholipase, proteinase, hyaluronidase and chondroitin-
sulfatase.(120) 
3. Chromosomal analysis using pulsed field gel electrophoresis (PFGE). This 
is the use of the heterogeneity in chromosomal number and patterns to 
identify Malassezia species. The method is time consuming, 
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methodologically demanding and the recently described species 
karyotypes are yet to be analysed.(120) 
4. Polymerase chain reaction (PCR) – based methods. These methods 
require the development and use of species-specific probes and are very 
common methods implored in Malassezia species identification. They 
consist of the Random Amplification of Polymorphic DNA (RAPD) and 
DNA fingerprinting; Restriction Fragment Length Polymorphism (RFLP) 
analysis and the Amplified Fragment Length Polymorphism (AFLP) 
analysis. In these methods a band pattern is generated per strain which is 
compared with available band patterns. Other PCR – based methods are 
the Terminal Fragment Length Polymorphism (tFLP) analysis in which 
amplicon lengths are compared; Denaturing gradient gel electrophoresis 
(DGGE) and single strand conformation polymorphism (SSCP) analysis in 
which the migration nature of single stranded DNA of species are 
compared. Also included is the species identification by the Luminex 
Technology whereby the probes are bound to latex fluorescent beads and 
species detected with the use of the Luminex analyser. The Real-time and 
multiplex PCR(120, 121) are additional PCR-based methods used in the 
identification of Malassezia species. 
1.8.3 Restriction Fragment Length Polymorphism (RFLP) PCR method. 
RFLP is a molecular biology technique that exposes the dissimilarity in homologous 
DNA sequences by identifying the presence of fragments of different lengths 
following digestion of this same DNA sample with specific restriction enzymes. 
Basically in RFLP analysis, the DNA sample is digested by restriction enzymes and 
the products of this digestion called restriction fragments are separated according to 
their lengths by gel electrophoresis. This method apart from identification of 
strains/species of microorganisms, has been used in various genetic studies for the 
location of mutations, generation of human linkage maps, identification of disease 
genes and in DNA fingerprinting where solutions to paternity cases, criminal justice 
can be applied.(122) 
Restriction enzymes are bacterial derived enzymes that recognize and cleave 
specific sequences in DNA to produce fragments. A common example of a restriction 
enzyme is EcoR I which is isolated from the bacterium Escherichia coli. This enzyme 
recognizes the sequence 5´-GAATTC-3´. Whenever EcoR I find this sequence in a 
DNA molecule, it cuts between the G and the first A. Another example is Sma I 
isolated from Serratia marcescens which recoqnizes 5´-CCCGGG-3´sequence and 
cuts between the last C and the first G. See figure 1.1.  
Since each enzyme recognizes one specific DNA sequence, each enzyme will digest 
a particular DNA molecule only at that specific point. Thus a DNA molecule that has 
just one 5´-GAATTC-3´sequence and is to be digested by EcoR I will be cut once 
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and if the same molecule has three 5´-CCCGGG-3´sequences that is recognized by 
Sma I, it will be cut thrice, producing 3 DNA fragments. These 3 fragments may have 
different length, that is base pairs, and they usually add up to the original size of the 
molecule. 
Figure 1.1 showing a DNA palindrome of the recognition sequence for EcoR I 
and Sma I with arrows indicating cut sites 
 
 
 
 
 
 
 
 
 
Studies in the identification of Malassezia species from PV lesions using PCR-RFLP 
method have used specific primers to amplify the 26S rDNA and the 5.8S rDNA-ITS2 
regions of the fungi. These amplified DNA sequences were then digested with 
specific restriction enzymes.(119, 123) The digested fragments were observed to 
give species-specific patterns which were comparable with known DNA sequences 
of the different species. Seven species can be identified with the 5.8S rDNA 
amplification product using Alu I and Hinf I restriction enzymes while 11 species can 
be identified with the 26S rDNA amplification product using Cfo I and BstF 51 
enzymes. See Table 1.6 and 1.7 below  
Table 1.4. Size of PCR products before and after restriction digestion with Alu I 
and Hinf I 
Malassezia 
species 
5.8S rDNA-ITS2 
amplification product 
(bp) 
Alu I digest (bp) Hinf I digest (bp) 
M. furfur 509 268, 241 483, 18, 8 
M. globosa 430 241,173,16 412, 10, 8 
M. obtusa 506 No restriction site 480, 18, 8 
      EcoR I            Sma I 
 
5´--------------GAATTC-----------3´   5´----------CCCGGG------------3´ 
3´--------------CTTAAG-----------5´   3´----------GGGCCC------------5´ 
 
 
Restriction site for EcoRI       Restriction site for SmaI 
  
 
-------G AATTC--------   ------------CCC      GGG-------- 
-------CTTA           G--------    ------------GGG      CCC-------- 
 “Sticky” end            “Blunt” end 
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M. slooffiae 486 368,118 403, 83 
M. restricta 410 No restriction site 392, 18, 8 
M. sympodalis 374 No restriction site 356, 10, 8 
M. pachydermatis 483 374,109 457, 18, 8 
 
Table 1.5. Size of PCR products before and after restriction digestion with Cfo I 
and BstF 51 
BstF 51 digest (bp) Cfo I digest (bp) 26S rDNA 
amplification 
product (bp) 
Malassezia 
species 
No restriction site 250, 109, 87, 64, 74 580 M. slooffiae 
400, 180 250, 113, 109, 59, 
30,19,2 
580 M. furfur 
No restriction site 250, 153, 109, 29, 
19, 18, 2 
580 M. obtusa 
500, 70 250, 221, 97,  580 M. pachydermatis 
480, 100 457, 127 580 M. globosa 
500, 70 No restriction site 580 M. restricta 
No restriction site 359, 199,21 580 M. dermatis 
No restriction site 250, 197, 62, 47, 21 580 M. nana 
No restriction site 165, 113, 108, 85, 
59, 30, 19,2 
580 M. yamatoensis 
400, 180 357, 197, 21 580 M. sympodialis 
No restriction 250, 220, 104, 5 580 M. japonicum 
 
1.9 Treatment of pityriasis versicolor 
1.9.1  Goal of treatment 
The goal of treatment of PV is to achieve both clinical and mycological cure. Clinical 
cure is the disappearance of the scaling and dyspigmented lesions of PV while 
mycological cure is achieved when the mycelial state of the causative yeasts, 
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Malassezia can no longer be identified in the lesions. Consequently, they have 
returned to their skin flora status. This is the state in which they are not associated 
with disease. However, assessment of an effective treatment is challenging since the 
yeasts remain on the skin surface a few weeks after cell death while the reversal of 
pigmentation takes a slow course up to several weeks therefore giving the 
impression of no response. 
Treatment of PV could be via the topical and/or systemic route. Almost all the drugs 
available are not specifically developed to treat PV but can also be used to treat 
other superficial dermatomycosis both Malassezia and non-Malassezia associated. 
These medications are largely safe with minimal side effects and some are cost 
effective. However the high recurrence of the infection and patients’ adherence to 
treatment could affect management.  
1.9.2 Topical treatment 
There are numerous topical medications available to treat PV; they are classified into 
the non-specific and the specific topical anti-fungal agents. The application of topical 
medications is easy although patient compliance may affect their effectiveness. The 
non-specific drugs are the oldest and first available treatment for PV and they do not 
have any direct antifungal activity but generally act by removing infected superficial 
epidermis and prevent invasion of newly formed ones.(124)  There are also non-
fungal specific forms of treatment that have been added most recently in the 
literature. Examples of some of the non-specific topical antifungal agents are 
highlighted below; most were reviewed by Gupta et al.(99) 
1. 2.5% Selenium sulphide which could be used as a lotion, cream or shampoo 
is one of the first and oldest treatment options of PV. It is also effective though 
associated with a high relapse rate. 
2. There is 5% or 10% benzoyl peroxide gel which contains propylene. This 
agent is effective after 3 weeks. Its mode of action may be due to the 
propylene glycol which is a keratolytic agent. 
3. Whitfield’s ointment consists of 3% salicylic acid and 6% benzoic acid. The 
combination of these two components gives the ointment its keratolytic 
property. 
4. The effectiveness of the shampoo containing 1% zinc pyrithione in PV 
treatment is usually noticeable after 2 weeks. 
5. 50% propylene glycol in water is also a non-specific antifungal medication 
used in the treatment of PV. The lesions are said to clear when used alone, 
twice daily for 2 weeks. 
6. Sulphur and salicylic acid shampoos or creams have shown good efficacy in 
the treatment of PV. 
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7. Nitric oxide liberating cream has also been used in PV treatment. A 10 day 
twice daily application is effective.(125)  
8. 0.2 mol/liter aqueous cycloserine solution was used in a 3-patient study. It 
was observed to give complete healing and rapid pigment correction.(126) 
More studies with a larger study population are required to confirm this 
observation.  
9. 5-aminolevulinic acid photodynamic therapy has also been used in PV 
treatment but it is limited to regionally confined lesions,(127) thus cannot be 
used for extensive PV. 
10. Adapalene gel was used recently in a PV treatment clinical trial and it showed 
no clinically effective difference with ketoconazole.(128) 
The specific anti-fungal agents used in PV treatment are mainly the azoles and 
allylamines. They work by inhibiting enzymes involved in the synthesis of the fungal 
cell membrane. Specifically, they inhibit the biosynthesis of ergosterol, the main 
sterol in the fungal cell membrane. The azole derivatives also distort the synthesis of 
triglycerides and phospholipids which are components of enzymes involved in 
oxidative and perioxidative enzyme activities. The accumulation of highly toxic levels 
of hydrogen peroxide may contribute to the deterioration of subcellular organelles 
and cell necrosis commonly observed when these medications are used.(129) Some 
of the specific topical antifungal medications used in the treatment of PV highlighted 
below include the following, all of which were reviewed by Gupta et al.(124) 
1. 2% ketoconazole shampoo or cream. This is quite effective and is retained for 
a long time in stratum corneum. 
2. 1% bifonazole cream, spray, solution and gels produces irreversible changes 
in the yeasts. A 3-day treatment is highly effective. 
3. 1% clotrimazole cream or solution is a broad spectrum imidazole used 
commonly in superficial fungal infections. 
4. 2% miconazole cream is effective when used twice a day for 2 weeks. 
5. 1% econazole foaming solution, cream or shampoo is effective when used 
once daily. 
6. 1% or 2% sertaconazole cream is also an effective PV medication. 
7. 2% fenticonazole lotion is effective in PV. 
8. 1% tioconazole lotion or solution is a 1-substituted imidazole with shown 
effectiveness in PV treatment. 
9. 2% fluconazole shampoo is considered effective in PV 
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10. 1% terbinafine solution, emulsion and cream also contains propylene glycol. It 
is highly lipophilic and has long lasting effect. 
11. 1% ciclopirox-olamine solution or cream is a substituted pyridine, unrelated to 
the imidazole derivatives but more effective than clotrimazole. It also has anti-
inflammatory properties. 
1.9.3 Systemic treatment 
Systemic treatment of PV is known to increase patient compliance since the 
treatment is more convenient and less time consuming than topical medications. 
This is the preferred mode of treatment for extensive PV which is PV affecting large 
skin surface areas. Systemic treatment has been used as prophylaxis in recurring 
cases. 
Common drugs used include: 
1. Ketoconazole 200 mg/day for 5, 10 and 28 days.(124) It is the first significant 
oral imidazole developed to treat many fungal infections. Some studies have 
recommended a single dose of 400 mg.(130, 131) Ketoconazole can be 
excreted through the sweat glands and this is the major route by which it 
rapidly reaches the stratum corneum. Thus, patients should not bathe for 12 
hours after taking the drug.(130) It is a cytochrome P-450 enzyme inhibitor. 
Although no side effects have been documented with its use in PV treatment, 
oral use of ketoconazole is being discouraged by the United States Federal 
Drug regulation Agency (FDA). This is why there is need to discover a more 
accessible and affordable replacement. 
2. Terbinafine used orally has not shown good results in treating PV as the level 
of its antifungal properties are quite low in the stratum corneum in patients 
with PV since it is not excreted through the sweat glands as ketoconazole or 
sebum as itraconazole.(4) 
3. Itraconazole has been shown in vitro to be active against Malassezia by 
inhibiting its transformation into the mycelial form from the yeast form and 
also induces cell wall abnormalities.(132) It is extensively excreted in the 
sebum and persists in the basal layer of the epidermis (the reservoir effect). 
Most fungal pathogens respond to a plasma concentration of 100 ng/ml of 
itraconazole(133) which translates to 5 days of 200 mg daily. However, some 
clinical trials have shown an effective treatment of PV with itraconazole at a 
single dose of 400 mg/day and 200 mg/day for 7 days.(132) 
4. Fluconazole is used in the systemic treatment of PV at an effective weekly 
dose of 400 mg, 300 mg and 150 mg for as long as 2 to 4 weeks.(124) This is 
because of its slow elimination rate from the skin. It selectively inhibits fungal 
cytochrome P-450 enzymes than other azoles and thus has a better safety 
profile.(134) 
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5. Pramiconazole, a broad-spectrum triazole antifungal has been shown to be a 
convenient short duration therapy for PV. It is effective at a 200 mg or 400 mg 
taken once or a 200 mg daily dose for 2 or 3 days.(135) 
1.9.4 Herbal treatment of pityriasis versicolor 
This involves the use of plant extracts. Some have been studied in vitro and shown 
to be effective for PV treatment; however evidence of efficacy is yet to be evaluated 
by randomized controlled clinical trials. Examples include Xanthorrhizol extracted 
from the rhizome of Curcuma xanthorrhiza and found to kill 100% of M. furfur and M. 
pachydermatis inoculated cells.(136) 
Australian tea tree oil is an essential oil of Melaleuca alternifolia that has shown good 
in vitro activity against six common Malassezia species.(137) 
Other plant extracts shown to have therapeutic properties in PV include Acalypha 
wilkesiana,(138) Cassia alata,(139) Ilex paraguariensis(140) and Artemisia 
abrotanum.(141) 
1.9.5 Prophylactic treatment of pityriasis versicolor 
The importance of above mentioned endogenous and exogenous predisposing 
factors increases the tendency of PV to recur especially in individuals living in 
tropical environment and who have a genetic predisposition. This could be quite 
distressing and frustrating to both the patients and their physicians(142) 
necessitating the need for the development of an effective guideline for prophylactic 
treatment. 
A study from Israel in which the patients with PV were followed up for up to 2 years 
showed a relapse rate of 60%(143) although this rate could be as high as 90% in 
some cases.(4) Patients with PV can have 4 or more relapsing episodes within 12 
months despite adequate treatment.(144) Also the number of relapsing episodes is 
not significantly linked to the extent of distribution of the lesions.  
Oral therapy has been used in clinical trials at variable doses and methods as a form 
of prophylaxis in PV patients. Patients were followed-up for variable length of time. 
Examples include the use of ketoconazole at 400 mg single dose per month and 
followed up for a year or 200 mg per day for 3 consecutive days per month and 
followed up for up to 15 months; both studies showed low rate of recurrence.(144, 
145) Also is the use of 400 mg single dose per month for 6 months of itraconazole 
which was shown to significantly delay recurrence than placebo.(146) However, 
there are no consensus guidelines available for the prophylactic treatment of PV. 
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CHAPTER TWO  
Rationale and Objectives 
2.1. Rationale 
Pityriasis versicolor is a common superficial fungal infection of the skin caused by 
Malassezia. Nigeria is one of the tropical countries with its main latitude and 
longitude lying 10 degree North of the Equator and 8 degree East of the Greenwich 
Meridian respectively. It is located in the western region of Africa and considered as 
one of the most populous areas of black population. 
Figure 2.1 Map of Nigeria in Africa showing the latitude and longitude 
 
The climatic condition in the northern part is arid while the south is tropical in nature. 
PV has a higher prevalence rates in tropical and arid regions.  It is most prevalent in 
adolescents and young adults and is chronically recurring such that affected 
individuals can have a prolonged course of the disease. It has various clinical 
presentations and a strong familial tendency.  
Fourteen species of this organism have been identified and studies have shown 
significant differences in response to treatment by these species. The distribution of 
the different Malassezia spp. recovered from PV lesions have been speculated to be 
determined by the differences in geographic or climate conditions, ethnic origin of the 
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population, body site, specimen collection and identification methods.(108) And yet, 
studies from the tropical regions of the world are very few in number. 
A summary of several studies done to determine the causative species in most PV 
lesions have shown M. globosa, M. sympodialis and M. furfur as the three dominant 
Malassezia species.(108) There is also a major geographical location difference 
among these species with M globosa being more prevalent in temperate regions and 
M furfur in tropical regions of the world, although the other Malassezia species do 
exist. The predominant species in West Africa has not well been studied. The clinical 
characteristics of PV among Africans need to be updated. 
The rationale for this study is to see if there is any association between the clinical 
features and causative species of Malassezia in this environment which may 
influence treatment.  
2.2  Research question(s) and/ or hypotheses 
1. Which of the Malassezia species isolated is more prevalent in Nigeria? 
2. Is there an association between the species and clinical characteristic? 
3. How does PV affect the quality of life of affected individuals? 
2.3 Objectives 
To identify the existing Malassezia species in Nigerian students with pityriasis 
versicolor and to correlate the various species with the clinical characteristics of the 
lesions 
Aim of study: 
1. To identify the prevailing species of Malassezia causing PV.  
2. To describe the clinical characteristics of PV. 
3. To describe attitude and health related quality of life effect of PV on affected 
subjects. 
Objectives: 
1. To identify the most prevalent species of Malassezia in Nigerian subjects. 
2. To determine if the clinical morphology of PV lesions is species specific. 
3. To identify possible predisposing factors contributing to development of PV.  
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CHAPTER THREE 
Subjects, Materials and Methods 
3.1 Study design  
The research was a descriptive/cross-sectional survey, carried out over an eighteen 
month period (January 2012 to October 2013) with ethical approval obtained both 
from the Ethics Review Committee of National Hospital Abuja, Nigeria and Ludwig 
Maximillian University Munich, Germany. 
3.2 Study location  
The subjects and sample collection part of the study was conducted within the 
Federal Capital Territory (FCT) of Nigeria while a part of the laboratory work namely 
PCR-RFLP was done in the Department of Dermatology Ludwig Maximilian 
University (LMU) Munich, Germany and later for logistics reasons at the Department 
of Molecular Biology, Nigerian Institute for Medical Research (NIMR) Lagos state, 
Nigeria.  
The Federal Capital Territory of Nigeria, Abuja is located at the center of the country, 
Nigeria. It is a recent capital city and was designed to signify neutrality where all 
ethnic groups can live in a sense of national unity. It officially became the seat of 
power on 12 December 1991, replacing Lagos, which remains the city with the 
highest population of Nigerians. Abuja as a planned city is still expanding and 
undergoing various construction.   
Figure 3.1 Showing a Map of Nigeria with its 36 states and FCT 
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It is divided into six area councils. The area councils include Bwari, Gwagwalada, 
Municipal (city center) Area Council, Kuje, Abaji and Kwali. The estimated population 
of Abuja for 2013 by the 9th edition of the Demographia World Urban Areas of March 
2013 is about 2.36 million making it the fourth largest city after Lagos, Kano and 
Ibadan. Unlike other cities in Nigeria, Abuja is not dominated by any tribe or ethnicity 
and the native people who lived there before it became the country’s capital are 
considered a minority group.  
Abuja’s climate is tropical wet and dry under the Köppen climate classification.(8) It 
experiences three seasonal weather conditions annually. The first is the rainy 
season from April to October, when the atmospheric temperatures range from 220 C 
to 300 C. The second is called the dry season (without any rains) from November to 
March, when the temperatures vary from as low as 120 C to as high as 400 C. Within 
the dry season, in December/January there is usually a short period of the harmattan 
season caused by the northeast trade winds which blows in fine dust particles from 
the Sahara into the Gulf of Guinea. It is characterized by dust haze and an intensity 
of cold as well as dry weather. According to Wikipedia, the dust haze can impair 
visibility and sun exposure for several days; atmospheric temperature can be as low 
as 50 C while humidity may drop to 15 percent.  
Most of the laboratory work for the study namely the culture media preparation, 
incubation of the fungi, DNA extraction and storage of extracted culture were done at 
the National Hospital Abuja one of the tertiary hospitals located in Abuja. 
Figure 3.2 Showing Abuja Area Councils 
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3.3 Study population 
The study population consisted of senior secondary (SS) students from year one to 
three (final year) who had clinical features of PV as well as positive culture growth of 
the fungus from the lesions. The students were consecutively selected from the 
Government Secondary Schools (GSS) in Abuja. They included a wide range of 
Nigerians from different ethnic groups and social backgrounds.  
For a student to be in the senior secondary school, he or she must have spent at 
least 6 years in primary school, passed the National Common Entrance Examination 
to enter the Junior Secondary School and after at least 3 years of junior secondary 
education, must pass the Junior Secondary School Certificate Examination in order 
to begin his or her senior secondary education. The minimum time spent in this 
education is three years. Due to the above reasons, the expected age range of the 
students in this study population (SS one to three) should lie between 13 up to 16 
years. However, this may not be the case as the age range of the students in each 
class varied widely with some students being as old as 22 years. Some students 
may have commenced their education later than others or took a break from school 
or are slow in learning. The reasons are usually socioeconomically related. 
Meanwhile, the rate limiting step used in the students’ placements include mainly the 
School Entrance, Certificate and Class Examinations. Therefore, students are placed 
in classes based on the level of their intellectual capacity as shown by their success 
at these examinations. Age, especially when older, does not usually play a major 
role.  
The schools selected were randomly distributed within the six area councils of Abuja. 
Permission was obtained from the FCT Secondary School Management Board in 
order to gain access to the schools (appendix V). The Board controls 57 GSS 
distributed randomly in all the area councils. Some area councils have more schools 
than the others and a bigger student population. For example Abaji and Kwali have 3 
and 4 senior secondary schools, respectively, while Municipal Area council has 22. 
These schools are attended by both girls and boys alike and comprise mostly of Day 
schools while the Boarding schools are just 5 in number.  
3.4 Sample size determination 
The sample size calculation was done based on the prevalence rate of 6.7% 
(prevalence of PV in Northwestern Nigeria).(55) Using the formula 
n = 2zpq/d2  
n = sample size 
p = 0.067 (prevalence of PV in Northwestern Nigeria) 
q = 1 - p 
39 
 
d = 5% (degree of accuracy desired) 
The calculated sample size was 96.1  
Samples could only be collected when the schools were open. Basically most of the 
first year senior secondary students are registered and admitted late into the first 
term since they have to await the result of their junior secondary school certificate 
examinations and some may have to change/transfer schools. Also from the second 
term of the session, the third year students commence their senior secondary school 
certificate examinations. Therefore at any point in time about 20 to 30% of the 
students may not be assessable for the research. Furthermore, there were students 
who could refuse to participate. To compensate for the above reasons, a new 
sample size using 30% was calculated as  
corrected sample size = 96.1 divided by (1-0.30). Thus new sample size is 137.3 
Considering that we had to analyze the identification of Malassezia species in 
relation to the clinical features of PV, and using the culture based technique, a 
growth rate of 50% is expected.(100) This increases the minimum sample size to 
275 [that is calculated from 137.3 divided by (1-0.5)].  
Students were recruited into the study based on their satisfaction of the inclusion 
criteria (shown below). A total of 304 students were included in this study. 
3.4.1 Inclusion Criteria 
1. Students with clinical features of pityriasis versicolor and whose skin 
scraping’s culture result showed growth of the Malassezia fungus. 
2. Students whose parents and self, voluntarily consented to participate in 
the study. 
3.4.2 Exclusion Criteria 
1. Students who claim to have had PV but do not currently have clinical 
evidence of PV.  
2. Students with PV who have used any topical antifungal medications in the 
previous 2 weeks or systemic antifungal agents in the previous 1 month. 
3. Those who are under 18 years of age whose parents did not give consent 
to the study. 
4. Students who are immunocompromised or chronically ill. 
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3.5 Selection Technique 
The study was conducted from January 2012 to October 2013. The students were 
recruited from May 2012 to May 2013 during the period the schools were in session. 
There are three terms of 2 to 3 months period within a school year. Recruitment was 
not done during the holidays.  
Average number of students per class was estimated at 40. Average number of 
classes per school-year was estimated as 6. Assuming that within the study period, 
second year students and either first or third year students will be available for the 
study; the average student population per school who may be available for the study 
was then estimated as 480.  
Using a prevalence of 6.7%, expected average number of students with PV per 
school is 32. Therefore, visit to a minimum of 10 schools was required in order to 
attain the calculated sample size. These schools were selected from the pool of 57 
schools by simple random sampling. On visit to the schools, the Principal was 
informed about the study and the letter from the FCT board presented to him or her. 
The Principal then directed the head teacher in charge of health and the school 
nurse to assist with the study. A convenient date when the study could begin was 
usually selected by the school authorities. The study period in each school (this 
includes timing for students’ education, collection of consent and skin scrapping of 
PV lesions) was on average seven days and it was dependent on the student 
population. 
The students were addressed and information about pityriasis versicolor provided to 
all the students who were present in their classes and on the Assembly Ground. The 
students with PV who voluntarily presented themselves were given the consent form 
and parents/patients information form (appendix I) for subsequent presentation to 
their parents/guardians. The following days, the students whose parents have 
already signed the consent form and who agreed to participate in the study as well 
as those who did not have any of the exclusion criteria stated above were examined 
at the School Clinic.  
They were examined by the dermatologist and allotted a number. They filled the 
questionnaire and skin scraping was collected and grown. Questionnaires not 
properly or completely filled by the student especially with regards to key aspects of 
the study were discarded. 
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Figure 3.3 Picture of one of the schools used in the study 
 
 
Figure 3.4 Picture of the school clinic where samples were collected 
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3.6 Data Collection Instrument 
Information was obtained from the students using a pre-tested questionnaire 
(appendix II). The questions were simple and easy to understand. The questionnaire 
was divided into four sections: section A for collection of demographic data, section 
B on history related to PV infection including personal grooming habits, after school 
activity and family history of PV. Section C was questions from the Children’s 
Dermatology Life Quality index (CDLQI). All ten questions of the CDLQI were 
obtained with the permission of copyright holders, Prof. Andrew Finlay and Dr. 
Lewis-Jones of Cardiff University, United Kingdom. It consisted of questions 
structured under 6 headings: symptoms and feeling (questions 1 and 2), leisure 
(questions 4, 5 and 6), school or holiday (question 7), personal relationship 
(questions 3 and 8), sleep (question 9) and treatment (question 10).  Section D 
contained records of the clinical pattern and distribution of the PV lesions as well as 
the result of laboratory investigations. This section was completed by the principal 
investigator. The questionnaire was administered in English language which is the 
language spoken and also used for teaching in the schools. Knowledge of the 
English language is a prerequisite for admission into any of the schools. 
Nevertheless, since there was a possibility that some students may not have a clear 
understanding of the questions, provision was made to assist them with easier 
interpretations. This, however, was rarely utilized. 
3.6  Clinical Evaluation 
All the eligible students recruited into the study filled in the questionnaire. Thereafter 
a detailed physical examination was conducted in a well lit room with particular focus 
on the skin lesions. Photographs of some lesions were also taken. 
PV was diagnosed as macules of different shapes which may coalesce into large 
irregular patches. They may have overlying thin scales which can be made more 
obvious by stretching the skin (Zileri’s sign).  The size of the lesions varied from a 
few millimeters to large confluent areas. 
The colours of the skin lesions were hypopigmented or hyperpigmented. Some 
subjects had a combination of the two. The lesions were distributed on the face, 
upper trunk, upper arms and back.  
The sites of involvement were divided into regions: face (perioral, around the nose, 
behind ears, cheeks, and forehead), chest, back, upper arm and others which 
includes lower limbs, scalp, and perineum. The number of regions involved were 
counted and grouped as localized when one region was involved and extensive 
when three or more regions were involved. This was used to grade the severity of 
infection. 
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3.7. Skin Scrapings  
Skin scrapings were collected from the clinical lesions with the use of OpSite 
transparent dressing (3 by 4 cm; Smith and Nephew Medical Ltd, Hull, United 
Kingdom) as described by Sugita and Saad et al.(76, 147) This was then placed on a 
glass slide for onward transfer to the laboratory. The site of scrapings was 
documented. Scrapings from adjacent healthy skin from the same student (as 
controls) were also collected. This was also collected with Opsite dressing. In 
subjects with PV involvement of more than two regions, samples were collected from 
the most accessible. In schools where a room with a dark background was available, 
wood’s light examination was also done. A part of the collected scrapings was used 
for direct microscopic examination with 20% potassium hydroxide plus lactophenol 
blue.  
A piece of the dressing was placed immediately on modified Dixon agar media 
consisting of 3.6% malt extract (Sigma-Aldrich Ltd), 0.6% peptone (Sigma-Aldrich), 2% 
desiccated ox bile (Sigma-Aldrich), 1% Tween 40 (Sigma-Aldrich), 0.2% glycerol, 0.2% 
oleic acid (Sigma-Aldrich), 1.2% agar (Sigma-Aldrich), 0.05 g/dL chloramphenicol 
and 0.05 g/dL cycloheximide (Sigma-Aldrich)(63). The medium was used within a 
week of preparation and the cultures incubated at 34°C for a maximum of seven 
days. The macroscopic feature of the fungal growth was compared with pictures of 
Malassezia species found in textbook written by Crespo Erchiga et al.(3)  
In some culture plates, there was contamination by other fungi species. Sometimes 
these species grew quite fast (within two days) and completely covered up the 
culture plate, preventing growth of the Malassezia yeasts. In these cases sub-culture 
of the growing Malassezia yeasts was done on to a fresh culture plate.  Catalase test 
and microscopy of culture was also matched to confirm Malassezia species growth. 
The morphology of the colonies was documented and two or three of these were 
selected and placed in microtubes and stored in -800 C freezer until use. The storage 
period varied from one to 10 months. 
Figure 3.5 OpSite transparent dressing used for scale collection 
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Figure 3.6 “Spaghetti and meatball” microscopy (x4) of PV scales 
 
 
Figure 3.7 Culture of Malassezia on mDA 
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3.8.   Isolation and identification of colonies compatible with Malassezia  
This was done using the PCR-RFLP identification method as described by Mirhendi 
et al.(123) There was some modification with regard to the extraction of genomic 
DNA from the culture. This was extracted using the heating and freezing method. 
3.8.1 DNA preparation: Heat-freeze method 
One ml of sterile water was added to microtubes containing Malassezia colony which 
was obtained from the -800 C freezer. It was then heated to 950 C in a dry heat block 
for 10 minutes. It was immediately transferred to a bowl containing liquid nitrogen 
and frozen. This heating and freezing sequence was repeated three times and the 
samples were allowed to thaw at room temperature and homogenized by vortex for 
10 seconds. There was no further DNA extraction, samples were used as prepared. 
3.8.2 PCR Procedure 
Primers that aim to amplify the 26S rDNA of Malassezia which has been verified to 
identify at least 11 species with the use of RFLP-PCR was used.(7, 71, 123, 148) 
Their sequences were: forward, 5’ – TAACAAGGATTCCCCTAGTA and reverse, 5’ – 
ATTACGCCAGCATCCTAAG. A final volume of 50 µL for each sample was used to 
perform PCR amplification. Each reaction contained 1 µL of the above prepared 
DNA sample, 10 µL of 5X Herculase buffer, 0.5U Herculase Hotstart DNA 
Polymerase (Agilent Technologies, Stratagene), 100mM each deoxynucleoside 
triphosphate (dNTPs), 10µM of each primer and 1µL of 100% DMSO. The rest of the 
volume was made up with DNA - free water. The mixture was done on ice with the 
help of a master-mix. 
The amplification carried out at the Department of Dermatology Ludwig Maximilian 
University Munich, Germany was performed with the Stratagene RoboCycler 40 
PCR machine while that done at the Department of Molecular Biology Nigerian 
Institute of Medical Research Lagos, Nigeria was carried out with the Eppendorf 
Mastercycler PCR machine using the same program. The program consisted of an 
initial denaturation step at 940 C for 5 minutes, followed by 40 cycles of denaturation 
step at 940 C for 45 seconds, annealing step at 550 C for 45 seconds and an 
extension step at 720 C for 60 minutes, thereafter a final extension at 720 C for 7 
minutes.  
Amplified products were visualized with the use of 1.5% (w/v) agarose (Sigma-
Aldrich) gel electrophoresis in TBE (Tris HCl, boric acid, EDTA) buffer and stained 
with RedSafe Nucleic Acid Staining Solution (iNtRON Biotechnology).  
The agarose was first boiled in microwave until the crystals were completely 
dissolved. On cooling to a level when the bottom of flask can be comfortably touched, 
5 µL of RedSafe was added and mixed before pouring into tray. Pouring was done 
from the edge to avoid bubbles. Formed bubbles were quickly removed. A comb was 
placed at one end and middle of the tray, then the agarose was left to solidify. 
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Following the solidification of the agarose, the combs were carefully removed. 
Fifteen microliter of each product plus three microliter of 6X gel loading buffer were 
then loaded into the pockets created by the combs in the gel. The electrodes were 
attached and left to run for one and half hours at a voltage of 100 V. Thereafter, the 
DNA bands were visualized and photographed under UV transillumination. The 
products successfully amplified by the primers were all expected to produce a single 
band of approximately 580 base pairs. 
3.8.3 Enzyme digestion 
Digestion of products with positive band was done with the Cfo I (Roche Applied 
Science) and BtsC I (New England BioLabs) restriction enzymes as described by 
other workers.(7, 71, 123) Digestion was performed with a final reaction volume of 
20 µL with 10 U and later 1.25 U of the enzymes. Incubation was at 370 C for 3 hours. 
Digested products were viewed with the use of 2.2% agarose gel electrophoresis in 
TBE buffer. The electrophoresis was done also at 100 V but for one hour only. 
Subsequently the gel was placed in a chamber containing one µg/ml of ethidium 
bromide. This was left for 20 minutes, then, placed in distilled water chamber for 5 
minutes before being read under UV transillumination. 
The bands generated were of variable predictable sizes depending on the 
Malassezia species. The base pair length used for identification is as in Table1.7 
above. Nine species can be clearly distinguished from one another using the Cfo I 
enzyme. These include M. furfur, M. pachydermatis, M. globosa, M. obtuse, M. 
restricta, M. slooffiae, M. nana, M. japonica, and M. yamatoensis; however, M. 
sympodialis and M. dermatis were shown to produce a similar pattern, which are 
357bp, 197bp, 21bp and 359bp, 199bp and 21bp respectively. Therefore, these two 
species were further differentiated using the enzyme BtsC I which is an isoschizomer 
(recognizes the same sequence) of BstF 51. 
Figure 3.8. In preparation to commence PCR showing the ice tray, 
                     microtubes, DNA-free water and the polymerase and enzymes 
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Figure 3.9. The Stratagene RoboCycler 40 PCR machine and the loaded gel 
           operating at 100 V 
   
 
Figure 3.10.  Staining with Ethidium Bromide and the Gel Documentation 
                      System where the DNA bands were visualized and photographed 
                      under UV transillumination 
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3.9 List of materials 
3.9.1 List of equipment: 
1. Sellotape 
2. Opsite flexi transparent adhesive 10cmx10cm roll (Smith and Nephew 
GmbH) 
3. Microscope slides. Cat. Number 7104 
4. Petri dishes 100 mm x 15 mm 
5. Autoclave machine 
6. Measuring scale 
7. Binder Incubator 
8. Thermocool Fridge 
9. -800 C freezer 
10.  Vortex machine  
11. Dry heat block 
12. Liquid Nitrogen 
13. 2ml Eppendorf tubes 
14. 1.5 Eppendorf tubes 
15. Tube racks 
16. Filtered pipette tips 
17. Unfiltered pipette tips 
18. Pipettes 20 µL, 200 µL, 1000 µL 
19. PCR tubes 
20. Stratagene RoboCycler 40 PCR Machine 
21. Eppendorf Mastercycler 
22. Gel electrophoresis apparatus 
23. Bio-Rad Gel Doc 2000 System 
24. Conical flask 
25. Siemens Microwave 
26. Microscope 
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27. Coverslips  
28. Camera  
29. Disposable nitrile gloves 
30. Disposable latex gloves 
 
3.9.2 List of Supplies and reagents: 
1. 3.6% malt extract (Sigma-Aldrich; Product Number: 70145) 
2. 0.6% peptone (Sigma-Aldrich; Product Number: 18332)  
3. 2.0% desiccated ox bile (Sigma-Aldrich; Product Number: 70168)  
4. 1.0% Tween 40 (Sigma-Aldrich; Product Number: P1504)  
5. 0.2% glycerol 
6. 0.2% oleic acid (Sigma-Aldrich; Product Number: O1008)  
7. 1.2% agar with pH of 6.0 (Sigma-Aldrich; Product Number: 05039)  
8. 0.5% chloramphenicol 
9. 0.5% cycloheximide (Sigma-Aldrich; Product Number: 18079) 
10. Distilled water 
11. Sterile water 
12. DNA – free water 
13. 20% potassium hydroxide 
14. Lactol phenol blue 
15. Herculase Hotstart DNA Polymerase (Agilent Technologies, Stratagene; 
Product Number: 600310) 
16. 10X Herculase buffer (Agilent Technologies, Stratagene; Product Number: 
600310) 
17. Herculase dNTPs (Agilent Technologies, Stratagene; Product Number: 
600310) 
18. DMSO (Agilent Technologies, Stratagene; Product Number: 600310) 
19. Forward primer, 5’ – TAACAAGGATTCCCCTAGTA (Eurofins MWG Operon)  
20. Reverse primer, 5’ – ATTACGCCAGCATCCTAAG (Eurofins MWG Operon) 
21. Agarose (Sigma-Aldrich; Product Number A9539) 
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22. RedSafe Nucleic Acid Staining Solution ( iNtRON Biotechnology; Product 
Number: 21141) 
23. Ethidium bromide solution 
24. 6X gel loading buffer (Sigma-Aldrich; Product Number: G7654) 
25. DNA SmartLadder – 200 to 10000 base pairs (Eurogentec; Product Number: 
08A31-2) 
26. Low molecular weight DNA ladder – 25 to 766 base pairs (New England 
BioLabs; Product Number: N3233S) 
27. Cfo I (Hha I) enzymes and buffer (Roche Applied Science; Product Number: 
10688541001 
28. BtsC I enzymes and buffer ( New England BioLabs; Product Number: R0647S) 
29. Icebox  
30. TBE buffer: Tris base 54 g, boric acid 27.5 g and EDTA 3.72 g in 1 L 
3.10 Statistical analysis  
Data generated from the study were entered, coded, and analyzed using the 
Statistical Package for Social Sciences (SPSS Inc, Chicago, IL) software version 
16.0. Descriptive variables were presented using frequency tables, pie charts and 
bar charts as appropriate. The student’s t-test was used to test for statistical 
difference between the age of the students and gender. It was also used between 
age of onset of PV and some clinical variables which included residence of the 
students, presence of PV in a nuclear family member, daily use of petroleum jelly, 
daily use of body cream, episodes of PV infection (first episode vs recurring), 
presence of dandruff and regular animal contact.  
Chi-square and Fisher exact tests as appropriate were used to test for independence 
between age group and the use of bleaching creams, having dandruff, recurrence of 
PV, residence of the students and presence of a family member with PV. Odds ratio 
was used to analyze the relationship between having a positive family history of PV 
and recurring PV. Chi-square was also used to test for independence between 
genders and some personal grooming habits as well as some clinical features. Odds 
ratio was used to analyze the relationship between genders and routine use of 
Vaseline and bleaching/toning creams. 
For the analysis of the health-related quality of life (HRQoL), a statistical difference 
between the total CDLQI score in relation to some clinical variable was analysed with 
the use of the independent student’s t-test. The clinical variables included age, 
gender, episodes of PV infection, family history of PV, site affected (exposed vs 
unexposed), number of body regions affected by PV, color of PV lesions and the 
presence of additional symptoms. Also used were the Spearman’s rank coefficient, 
one way analysis of variance ANOVA and the Fisher’s least significant difference 
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(LSD) post hoc analysis as appropriate to find the correlation between the students’ 
year in school and number of regions affected by PV. 
Chi-square test and Fisher exact test as appropriate were used to test for the 
association between the identified Malassezia species and the clinical variables 
mentioned above. A P-value of <0.05 was considered significant. 
3.11 Ethical Certificate 
Approval was obtained from the National Hospital Abuja Ethics Review Committee 
(appendix III) and the Ethics Commission of the Ludwig Maximilian University 
Munich Germany (appendix IV). Permission was also obtained from the FCT 
Secondary School Education Board Abuja (appendix V). Only students who were 
adequately informed and whose consent was obtained were included in the study. 
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CHAPTER FOUR 
Results  
4.1  Clinical characteristics of subjects 
A total of 304 students with clinical features of pityriasis versicolor (PV) were 
recruited from 10 senior secondary schools into the study between May 2012 and 
May 2013. Out of these, 175 skin samples of PV grew from the mDA culture medium. 
This produced a 57.6% growth rate. Mode of distribution is as shown in Table 4.1 
Table 4.1. Distribution of schools selected in the study  
The table shows the number of students recruited in each school and the number 
whose skin scraping had a positive culture growth. Government senior secondary 
(GSS) Kwali had the highest number of students with PV while GSS Wuse had the 
lowest number. There was no statistically significant correlation between the number 
of students recruited and number with positive culture growth. 
Schools Number of Students with PV 
recruited 
Number with positive culture 
growth 
GSS Gwarinpa 9 4 
GSS Garki 20 12 
GSS Jabi 18 10 
ADSS Maitama 18 8 
GSS Nyanya 42 24 
GSS Lugbe 53 35 
GSS Kuje 27 20 
GSS 
Gwagwalada 
50 27 
GSS Wuse 8 5 
GSS Kwali 59 29 
Total 304 175 
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4.1.1 Age characteristics of the students 
There were 118 males and 186 females (M:F 1:1.6). The age distribution is as 
shown in figure 4.1. The mean age of students with PV was 16.13 (95% Confidence 
Interval (CI) 16.03 - 16.30) years. The age group with the highest number of PV was 
14 - 18 years. The mean age of the male students with PV was 16.31 years (95% CI 
16.09 – 16.59) while the mean age of the females was 16.02 (95% CI 15.82 – 16.22). 
There was no statistically significant difference between the ages; P = 0.08. 
Figure 4.1.  Age distribution of the students 
This figure shows that a majority of the students with PV fell within the age group 14 
– 18 years. Most of the female students with PV were within the 16 to 17 age group. 
Both genders were equally distributed in those less than 13 years and 18 - 19 age 
groups. 
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4.1.2 Demography of students 
 
About half of the students recruited (51.6%) were in their second year (SS2) while 
the percentage of students in third and final year was the lowest at 10.9%. There 
was no significant difference between the male and female according to their classes, 
P = 0.51. The distribution is shown in Figure 4.2 
 
Figure 4.2.  Class distributions of the students 
The least number were students in senior secondary class 3 (SS3). 
 
 
The tribe of students recruited numbered up to 46. The tribes were from the different 
ethnic groups and state of origin found in Nigeria. However, the majority were Ibo 
(26.9%), next was Yoruba (15.8%) then Igala (7.6%) and there were about 15% of 
the students who did not fill in their ethnic origin.  
On the area of residence which was evenly divided into urban and rural areas, most 
of the students were recruited from Kwali and Gwagwalada Area Councils; see Table 
4.1 above. One of the schools had only 8 students with PV. This school GSS Wuse 
is located right in the city centre. 
Most of the students lived with their parents (78.9%) while the rest were residing with 
a Guardian. There were about 16% of the fathers and 26% of the mothers who had 
no formal education.  
The occupation of the parents was varied; however, trading was the occupation with 
the highest frequency by both parents.  
The students had diverse and multiple afterschool activities. These included 
household chores, playing football, cooking, reading, watching television, dancing, 
and singing. Others helped in the farms and shops of their parents. A few loved to 
play volleyball, basketball, table tennis, jog, swim and or visit friends. 
114 
157 
33 
SS1
SS2
SS3
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4.1.3  Personal grooming of the students 
Table 4.2.  The frequency of respondents with regard to their personal 
                      grooming  
Personal grooming of the students Frequency in Percentage (%) 
Daily bath  100% 
Use Tap water daily 75.7% 
Use toilet soap 48% 
Use medicated antibacterial soap 51% 
Use body creams 67.8% 
Use petrolatum (Vaseline® jelly) 51% 
Use bleaching and toning creams 14.5% 
Use talcum powder 32.2% 
Share body towel 34.2% 
Sweat excessively during the day 39.8% 
Sweat excessively at night 32.2% 
Notice worsening of PV and thinks PV is 
related to the climate or seasons 
46% 
Toilet soaps were the ordinary bathing soaps commonly used included “Lux”, “Joy”, 
“Premier”, Johnson baby soap etc. The medicated antibacterial soaps frequently 
used were “Dettol”, “Tetmosol”, “Delta” and “Lifebouy”. The common body creams 
used by the students included “Familia”, “Jergens”, “Nivea”, “Cocoa butter”. The 
beaching/toning creams are body moisturizers containing hydroquinone, highly 
potent steroids and/or mercury. These included “Tura”, “Fair and white”, “Funbact A”, 
“Dermovate”, “Rapid white”, “Skin light” and “Maxi tone” 
All the students took daily baths but not all used Tap water as routine source of 
water. More students used body creams than petrolatum, commonly called 
Vaseline® as their regular body moisturizer. Almost 40% of the students sweat 
excessively during the day while 14.5% use toning/bleaching creams. About half of 
the students recruited believed their PV infection is climate and seasons related 
especially when the atmospheric temperature is at its peak during the dry season. 
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Table 4.3. Differences in personal grooming and clinical features among 
                      genders. 
Grooming habits and 
clinical features 
Number of boys (%) 
Total number = 118 
Number of girls (%) 
Total number = 186 
P 
value 
Use toilet soap 64 (54.2) 83 (44.6) 0.56 
Use medicated soap 71 (60.2) 86 (46.2) 0.13 
Use talcum powder 19 (16.1) 79 (42.5) 0.01 
Use body cream 65 (55.1) 141 (75.8) ˂0.001 
Use bleaching creams 11 (9.3) 33 (17.7) 0.04 
Use Vaseline® 70 (59.3) 85 (45.7) 0.02 
Sweat during the day 50 (42.4) 71 (38.2) 0.47 
Family history of PV 40 (33.9) 71 (38.2) 0.47 
Symptomatic PV 46 (39) 83 (44.6) 0.34 
Associated dandruff 12 (10.2) 55 (29.6) ˂0.001 
The percentage of boys who used toilet soap and or medicated soaps daily was 
higher than that of the girls but this difference was not statistically significant. 
Meanwhile, more girls than boys used talcum powder, body creams and 
bleaching/toning creams and the differences were found to be significant. There was 
a significant difference between the genders with regards to the use of Vaseline®. 
Exactly 1.7 times more male students used Vaseline® as routine body moisturizers 
when compared with the female students (95% CI 1.09 – 2.76). The presence of a 
positive family history of PV in a member of the nuclear family, sweating during the 
day and associated symptoms of pruritus or tingling sensation was not significantly 
different between the two genders. Also observed as insignificant is the difference in 
having recurring episodes of PV and the number of body sites involved. The female 
students with PV were also observed to have dandruff 2.7 times more than their 
male counterparts (95% CI 0.14 – 0.53). 
4.1.4 Family relations with PV 
A little above one third of the students (36.5%) had at least one member of their 
nuclear family who also suffers from PV infection. The distribution is as shown in the 
figure 4.4 below. The siblings were more affected than the parents (21% vs 16%).  
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The relationship between the age of onset of PV and the presence of a family (within 
the nuclear family) member with PV was further analysed. The mean age of onset of 
PV in those with a positive family history of PV was younger at 13.3 (CI 12.9 – 13.7) 
years while the mean age of those without a family history of PV was 13.9 (CI 13.5 – 
14.2) years. The difference between these groups of students was statistically 
significant at P = 0.03. (Shown in Table 4.4 below)  
There was no significant association between the presence of a family member with 
PV and the possibility of having recurring PV (odds ratio for family history [yes/no] 
1.5; 95% CI 0.94 – 2.55).  
Also, there was no significant relationship between the area of residence of the 
students (urban vs rural) and the presence of a family history of PV (P = 0.4).  
Figure 4.3. Showing distribution of family relations with PV 
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4.2 Clinical features and characteristics of PV 
4.2.1. Age of onset of PV 
The average age of onset of PV among the students was 13.7 years (95% CI 13.4 – 
13.9 years). The median was 14 years while the minimum age of onset was 5 years 
and the maximum was 19 years. The mean age in males was 13.9 years (C.I. 13.5 – 
14.4 years) and the females were younger at 13.5 years (13.1 – 13.9 years). The 
difference in the means was not statistically significant, P = 0.15. 
The area of residence by the students was divided into rural and urban. The rural 
areas are regions more likely to have untarred roads and lower cost of housing as 
well as food. People with lower income usually reside here thus they are more 
populated than the urban region. These areas are also known as satellite towns. The 
rural regions selected in this study included Gwagwalada, Kwali, Nyanya, Kuje and 
Mararaba. The urban areas are close to or within the city centre. They are less 
populated because of the higher cost of housing and living expenses. About 157 
(53.6%) students were from the satellite towns while those from the city centre were 
147 (46.4%). The students who resided in the rural part of Abuja developed PV at a 
younger age (mean age of onset was found to be 13.3; 95% CI 12.8 – 13.6 years) 
compared with students living in the city centre [mean age was 14.2 (95% C.I. 13.8 – 
14.6) years]. The difference between the 2 means was statistically significant, P = 
0.001. See Table 4.4. 
A large number of the students (69.1%) had recurring episodes of PV infection while 
for 94 students (30.9%); there was no history of recurrence. There was no 
statistically significant difference between the students who had recurring and first 
episode of PV with regards to age, sex, age of onset, family history, symptoms, 
colour and locations of lesions. See Figure 4.4. 
Figure 4.4.  Number of students with recurring and first episode of PV 
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Table 4.4.  The clinical characteristics in relations to the age of onset of PV 
 Mean age of onset 
of PV in years 
(95% CI) 
Mean age of onset of 
PV in years (95% CI) 
P 
value 
Residence of student Satellite towns  
13.2 (12.8 – 13.6) 
City centre 
14.2 (13.8 – 14.6) 
0.001 
Presence of nuclear family 
member with PV 
Positive  
13.3 (12.9 – 13.7) 
Negative  
13.9 (13.5 – 14.2) 
0.03 
Daily use of Vaseline® 
jelly 
Yes  
13.3 (12.8 – 13.7) 
No  
14.1 (13.7 – 14.5) 
0.004 
Daily use of body cream Yes  
13.6 (13.2 – 13.9) 
No  
13.8 (13.3 – 14.3) 
0.43 
Difference between first 
and recurring episodes  
First episode of PV 
13.8 (13.3 – 14.3) 
Repeat episode of PV 
13.6 ( 13.3 – 13.9) 
0.5 
Difference between those 
with/without dandruff 
Those with dandruff 
12.6 ( 11.9 – 13.2) 
Those without dandruff 
14.0 ( 13.7 – 14.3) 
0.001 
Regular animal contact Yes  
13.4 (12.9 – 13.95) 
No  
13.7 (13.4 – 14.04) 
0.37 
Also shown in this table is that students who routinely used Vaseline® or had 
associated history of dandruff developed PV at a significantly younger age than their 
counterpart who did not use Vaseline® or did not have dandruff. Meanwhile the 
younger age of onset of PV in students who used body creams, or had repeated 
episodes of PV or regular animal contact was not statistically significant. 
4.2.2. PV and possible predisposing factors 
Only 44 students (14.5%), majority of which were females admitted the use of skin 
toning/bleaching creams. A little over half (54.5%) of this group of students were 
either 16 or 17 years. Also the most frequent age of onset of PV in students who 
used bleaching/toning creams was observed in the 13 to 16 age group which was 
not different from the general student population (P = 0.18). Overall, the average age 
of students who used bleaching/skin toning products were older (16.3 vs 16.1 years) 
and the average age of onset was also older when compared with students who did 
not use bleaching/toning creams (14.3 vs 13.5 years). 
About 20% of the students had regular contact with animals either as house pets or 
kept livestock, however, this did not affect the age of onset of PV when compared 
with those without regular animal contact.  
Also 22% of the respondents had dandruff (pityriasis capitis) in addition to PV. PV in 
this group of students appeared at a younger age than those without dandruff (P = 
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0.001). Meanwhile, there was no significant association observed between the 
students who had dandruff and those who had recurrence of PV infection (P = 0.55). 
4.2.3 Symptoms and Signs of PV 
Table 4.5. Showing the percentage distribution of complaints experienced 
                      by the students.  
Complaints  Number of students Percentage (%) 
Skin lesions 304 100% 
Symptomatic:  
Pruritus  
Tingling sensation 
130 
106 
24 
42.8% 
34.9% 
7.9% 
Asymptomatic 174 57.2% 
Symptomatic complaints were documented for those students who said their PV 
lesions were pruritic or gave them tingling sensation. Interestingly, it was observed 
that those who sweat excessively during the day were twice likely to be symptomatic 
than those who did not have hyperhidrosis. This was statistically significant. The 
odds ratio for not symptomatic/symptomatic was 0.58, 95% CI 0.37 – 0.93. 
Statistically significant differences when compared to other clinical characteristics 
between patients who were symptomatic and asymptomatic were not observed. 
Figure 4.5. Showing the percentage distribution of the complaints 
                      experienced by the students.  
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Table 4.6.  Location of PV lesions  
Location Number of students Percentage (%) 
Back  101 24.2 
Face  189 45.3 
Chest  57 13.7 
Upper arm 27 6.5 
Neck  18 4.3 
Others  25 6.0 
This was categorized by body regions such as face, back, etc and not by the number 
or count of PV lesions. Affectation of the face had the highest frequency at 45.3% 
while the neck had the lowest at 4.3%. “Others” included scalp, nasal creases, lower 
limbs and abdomen.  Some students had involvement of more than one body region. 
 
Figure 4.6. Exposed and unexposed PV location 
 
A chart showing the number of students with PV lesions located at an exposed part 
of the body mainly face, neck, scalp, nasal creases and unexposed part of the body 
mainly chest, back and upper arms. About a third of the students had the PV lesions 
on an unexposed part of the body. 
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Table 4.7. Number of body regions infected with PV  
Number of body region 
involved with PV 
Frequency Percentage (%) 
1 208 68.4 
2 71 23.4 
3 21 6.9 
4 4 1.3 
Exactly 8.2% of the students had extensive PV (involvement of 3 or more body 
regions). A complaint of pruritus or tingling sensation was statistically associated with 
students who had extensive PV (χ2 = 8.237, P = 0.02). Most of the students had just 
one body region involved (68.4%). 
 
Figure 4.7. Colour of PV  
 
The pigmentations of the lesions observed were hypo- and hyperpigmented. Only 5 
students were observed to have a combination of both.  
14.5% 
85.5% 
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63 
 
Table 4.8. Patterns of PV lesions observed 
Pattern Frequency Percentage (%) 
Macules 167 85.2 
Guttate 7 3.6 
Follicular 17 8.7 
Confluent 5 2.6 
Most of the lesions were observed as dyspigmented macules with no specific pattern 
of arrangement. Only 3.6% appeared in a tear-drop (guttate) pattern and 8.7% had 
the follicular pattern of PV presentation. 
Figure 4.8. Hyperpigmented PV on mandibular region of the face 
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Figure 4.9. Hypopigmented PV on shoulders/upper arm 
 
 
Figure 4.10. Hyperpigmented PV located at the back 
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Figure 4.11. Extensive PV involving the face, neck and upper arm 
 
 
Figure 4.12.  Follicular PV at the shoulders 
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Figure 4.13.  Close-up of the follicular PV lesions, notice how each hair shaft 
                       is surrounded by hypopigmented macule 
 
4.2.4 Mode of treatment implored by the students 
Figure 4.14. Mode of treatment utilized by the students 
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Most of the students (36.8%) used antifungal creams to treat their PV infection while 
25.7% of the students did not try any form of treatment. 6.6% of the students used 
hydraulic fluids, mainly brake fluids and 4.9% used herbs as a form of treatment. The 
drugs used by the students were mainly antifungal medications taken via oral route 
such as ketoconazole, fluconazole and itraconazole. The “others” mode of treatment 
implored by the students were classified as inappropriate for PV management. They 
included antibacterial medications both topical and systemic, antiseptic soaps, 
“Nixoderm”, “Skin light” body cream, “Biocoten”, “Funbact-A”. 
4.3 Health related quality of life (HRQoL) of affected students with PV 
Table 4.9. Socio-demographic and clinical variables in relation to the mean 
                      total CDLQI score 
Variables  Mean total CDLQI (95% CI) 
Total score: 7.39 (6.73-8.06) 
P value 
Mean CDLQI by gender 
Male: n=118 (38.8%) 
Female: n=186 (61.2%) 
 
7.36 (6.23 - 8.49) 
7.41(6.58 - 8.23) 
 
0.95 
Mean CDLQI by age group 
≤13 years old: n=8 (2.6%) 
>13years old: n=296 (97.6%) 
 
4.75 (3.35 - 6.15) 
7.46 (6.78 - 8.14) 
 
0.002 
Mean CDLQI by residence 
Urban: n=141(46.4) 
Rural: n=163 (53.6%) 
 
7.11(6.14 - 8.08) 
7.64 (6.72 - 8.56) 
 
0.433 
Mean CDLQI by school year 
First year: n=114(37.5%) 
Second year: n=157(51.6%) 
Third year: n=33 (10.9%) 
 
7.27(6.17-8.37) 
7.32 (6.39 - 8.25) 
8.12 (6.07 - 10.17) 
 
 
0.505 
Mean CDLQI by age of onset  
<13 years: n=91(29.9%) 
≥13 years: n=213 (70.1%) 
 
7.41(6.18 - 8.83) 
7.38 (6.59 - 8.18) 
 
0.977 
68 
 
Mean CDLQI by episode of PV 
First episode: n=94 (30.9%) 
Recurring PV: n=210 (69.1%) 
 
8.85 (7.57 - 10.14) 
6.74 (5.98 - 7.50) 
 
0.006 
Mean CDLQI by family history 
Positive: n=111(36.5%) 
Negative: n=193 (63-5%) 
 
8.41(7.27 - 9.55) 
6.80 (5.99 - 7.62) 
 
0.021 
Mean CDLQI by site 
Exposed region: n=221 (72.7%) 
Unexposed: n=83 (27.3%) 
 
7.26 (6.47 - 8.05) 
7.73 (6.48 - 8.99) 
 
0.534 
Mean CDLQI by number of body 
region affected 
One site: n=208 (68.4%) 
More than one site: n=96 
(31.6%) 
 
 
6.78 (6.05 - 7.51) 
8.72 (7.35 - 10.08) 
 
 
0.014 
Mean CDLQI by color of lesions 
Hypopigmented: n=260 (85.5%) 
Hyperpigmented: n=44 (14.5%) 
 
7.24 (6.54 - 7.94) 
8.30 (6.26 - 10.33) 
 
0.271 
Mean CDLQI by associated 
symptoms with PV 
None: n=175 (57.6%) 
Present: n=129 (42.4%) 
 
 
6.34 (5.53 - 7.15) 
8.81 (7.73 - 9.89) 
 
 
<0.001 
   
In this study, the overall mean of total CDLQI was 7.39 (95% CI 6.73 - 8.06). In 
relation to some socio-demographic and clinical variables (Table 4.8.), the mean was 
significantly higher in those older than 13 years (P = 0.002). Girls had higher mean 
scores than boys and those who live in rural parts of Abuja had also higher mean 
scores but both differences were not statistically significant. Students with first 
episode of PV and a positive family history of PV had higher mean total CDLQI 
which was significantly different from the students with recurring episodes of PV as 
well as a negative family history (P = 0.006; P = 0.021 respectively). Although the 
mean total CDLQI increased with higher classes, those in third and final year senior 
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secondary school had the highest score and those in first year the lowest. No 
statistically significant correlation was observed (rs = 0.04, P = 0.505).  
Interestingly, the mean total CDLQI scores were higher in those whose PV first 
appeared when they were less than 13 years old and in those whose PV were 
located on a frequently unexposed body region such as chest, back or upper arm. 
Students with hyperpigmented PV lesions also had higher CDLQI scores (Table 4.8.). 
These differences were, however, not statistically significant when compared with 
students whose PV infection began when they were older than 13 years or had the 
lesions on exposed body region such as face and neck or who had hypopigmented 
PV lesions respectively. Further on the mean total score of CDLQI, the students who 
had PV on more than one body region and who had additional symptoms associated 
with PV had statistically significant higher scores. Further bivariate analysis showed 
the number of body regions affected by PV correlated positively with the mean total 
CDLQI (rs = 0.1, P = 0.021). The one way analysis of variance (ANOVA) revealed 
that students with three or more body regional involvement had significantly impaired 
QoL when compared with those who had just one body region affectation (F = 5.293, 
df = 2, P = 0.006) 
The mean of the CDLQI subscales are shown in Figure 4.16. The leisure axis had 
the highest score (1.70), followed by the symptoms and feeling axis (1.07) while 
holiday or school and sleep were closely tied as the axis with the least scores.  
Figure 4.15.  The mean of the subscales of CDLQI among the students.  
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The significant results from the mean total CDLQI were further analysed at the level 
of the subscales in order to know which axis contributed significantly to the quality of 
life score. This is shown in Table 4.9. The leisure category had the highest CDLQI 
among the subscales. It was significantly higher in those who were having the first 
episode of PV infection, who had more than one body region affected, who had a 
positive family history of PV and who had additional symptoms associated with the 
lesions. Further bivariate analysis showed the number of body region affected by PV 
correlated positively with the leisure subscale (rs = 0.1, P = 0.043).  However, the 
one-way ANOVA was not significant (F = 2.806, df = 2, P = 0.06). 
Essentially, the mean score of the students whose PV was pruritic or gave tingling 
sensation was significantly higher in all subscale except the treatment category when 
compared with those without additional symptoms. The mean score of those older 
than 13 years was significantly higher in the personal relationship and also 
symptoms and feeling category however, not in the other subscales. The score of 
those whose PV lesions were located on an unexposed body part was significantly 
higher in the sleep category but not in other subscales. Meanwhile there was no 
statistically significant difference observed in the treatment category.  
Table 4.10. Relationship of the mean scores of the CDLQI subscales and some 
                   variables 
Variable (no of 
students) 
S and F 
Mean 
Leisure 
Mean 
PR 
Mean 
S or H 
Mean 
Sleep  
Mean 
Tx  
Mean 
Sex:  
Male (118) 
Female(186) 
 
1.07 
1.07 
P=0.468 
 
1.77 
1.66 
P=0.574 
 
0.58 
0.46 
P=0.413 
 
0.47 
0.52 
P=0.628 
 
0.47 
0.51 
P=0.743 
 
0.82 
0.85 
P=0.774 
Age group 
≤ 13 years(8) 
>13 years(296) 
 
0.73 
1.08 
P=0.177 
 
1.10 
1.72 
P=0.049 
 
0.08 
0.52 
P=<0.001 
 
0.25 
0.50 
P=0.420 
 
0.25 
0.50 
P=0.382 
 
0.62 
0.85 
P=0.522 
Family history 
Yes (111)  
No (193) 
 
1.20 
0.99 
 
2.04 
1.51 
 
0.57 
0.47 
 
0.58 
0.45 
 
0.56 
0.46 
 
0.92 
0.80 
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S and F = Symptoms and feeling; PR = Personal relationship; 
S or H = School or Holiday; Tx = Treatment 
P=0.097 P=0.015 P=0.222 P=0.254 P=0.280 P=0.295 
Age onset: 
<13 years (91) 
≥13 years(213) 
 
1.33 
0.96 
P=0.004 
 
1.75 
1.69 
P=0.786 
 
0.46 
0.53 
P=0.501 
 
0.57 
0.46 
P=0.331 
 
0.46 
0.51 
P=0.649 
 
0.80 
0.86 
P=0.640 
PV Episode  
First (94) 
Recurring(210) 
 
1.20 
1.01 
P=0.103 
 
2.18 
1.49 
P=0.002 
 
0.62 
0.46 
P=0.085 
 
0.61 
0.45 
P=0.171 
 
0.61 
0.44 
P=0.130 
 
0.91 
0.81 
P=0.382 
Body parts: 
Exposed (221) 
Unexposed(83) 
 
1.06 
1.08 
P=0.615 
 
1.60 
1.97 
P=0.111 
 
0.48 
0.59 
P=0.660 
 
0.50 
0.49 
P=0.973 
 
0.42 
0.69 
P=0.019 
 
0.86 
0.80 
P=0.606 
No. of sites 
One site(208) 
>one site(96) 
 
1.04 
1.14 
P=0.072 
 
1.57 
1.99 
P=0.041 
 
0.48 
0.58 
P=0.274 
 
0.43 
0.65 
P=0.065 
 
0.46 
0.57 
P=0.237 
 
0.79 
0.96 
P=0.156 
PV symptoms 
No (175)  
 
Yes (129)  
 
 
0.86 
1.35 
P=0.001 
 
1.42 
2.09 
P=0.002 
 
0.40 
0.64 
P=0.017 
 
0.39 
0.64 
P=0.014 
 
0.34 
0.70 
P=<0.001 
 
0.78 
0.93 
P=0.174 
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Questions were asked on how the students with PV perceived themselves when 
compared with other students. These questions included if they felt ashamed having 
PV, if they have low self-confidence and if having PV has prevented them from 
making friends. Their response was analysed with the mean of the total CDLQI. The 
results showed that slightly less than two-third of the students felt ashamed (64.0%) 
and acknowledged having low self-confidence (60.4%) while about one-sixth of the 
students (16.2%) agreed that PV did prevent them from making friends. The mean 
total CDLQI scores were higher in these three categories; however, the difference 
was only significant in those with low self-confidence and those who had difficulty 
making friends (Table 4.11 below.). 
Table 4.11.  Relationship between the mean total CDLQI scores and 
                      perception of the students 
Variables  Mean total CDLQI P-value 
Feel ashamed having PV 
Yes: n=71(64.0%) 
No: n=40 (36.0%) 
 
8.85 (7.5 - 10.18) 
6.82 (4.89 - 8.76) 
 
0.80 
Has low self-confidence 
Yes: n=67 (60.4%) 
No: n=44 (39.6%) 
 
9.16 (7.81 - 10.52) 
6.52 (4.72 - 8.33) 
 
0.019 
PV prevents from making 
friends 
Yes: n=18 (16.2%) 
No: n=93 (83.8) 
 
14.78 (11.93 - 17.63) 
6.83 (5.81 - 7.84) 
 
<0.001 
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4.4. Culture and microscopy results 
Figure 4.16. (a) Culture results of Malassezia species showing white glistening  
                           smooth surface and grooved edges. The texture was soft 
 
               (b) Showing cream coloured glistening smooth surface colonies and   
                     slight central elevation which is characteristic of M. sympodialis 
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                (c)  This is in keeping with M. restricta showing colonies with dull  
                       surfaces, smooth edges and average diameter of 3mm. The  
                       texture was hard and brittle.  
  
 
               (d)  These colonies are characteristic of M. furfur with smooth surface,  
                      convex elevations, average diameter of 5mm and soft texture 
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Figure 4.17.  Microscopy of Malassezia culture showing the unipolar, enteroblastic   
                      budding from a characteristic broad base of large, oval cells.      
                      Separation leaves a prominent bud scar through which successive  
                      daughter cells emerge. (x400 magnification) 
(a)  
 
(b)  
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4.5. Malassezia species identified 
Only three species were identified in this study; namely M. furfur, M. sympodialis and 
M. restricta. There were 175 samples collected from PV lesions which grew on the 
modified Dixon agar. Out of this number 143 (81.7%) were identified as M. furfur, 9 
(5.1%) were M. restricta while 4 (2.3 %) were M. sympodialis. Exactly 10.9% of the 
cultured samples did not show an identifiable band on PCR despite several repeats 
done on DNA extraction. 
The species distribution according to body site is as shown in Table 4.12 below. The 
PV lesions on the face had a 50% species identification rate while the back lesions 
had a higher yield at 61.2%. These two were the only sites where the three identified 
species were all isolated. The site with the highest positive species identification 
from culture was the scalp (80%) followed by the chest (68.6%) but just two species, 
M. furfur and M. restricta, could be isolated from these locations. Meanwhile, only 
one species, M. furfur was isolated from the upper arms lesions. Further, analysis 
did not find any significant correlation between the species identified and clinical 
features of affected students. 
Skin samples were also collected from normal (non-lesional) skin. The scales 
collected were limited to the sebum-rich body regions. A total of 110 samples were 
collected, out of which growth was established in 58 (52.7%) cultures. M. furfur was 
identified in 45 (77.6%), M. restricta in 6 (10.4%) while no PCR band was seen in 
7(12%). The species distribution according to body site is shown in Table 4.13 below. 
M. restricta was isolated only from the head and neck region and similar with species 
isolation from PV lesions, the face had about 50% species identification rate. This 
was lower than the percentage yield obtained from other body regions. 
Table 4.12. Distribution of Malassezia species isolated from PV lesions 
       according to body sites 
Body site M. furfur M. sympodialis M. restricta No growth 
face 79 1 3 82 
back 25 2 3 19 
chest 23 0 1 11 
Upper arm 8 0 0 12 
neck 6 1 0 5 
scalp 2 0 2 1 
Total  143 4 9 129 
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Table 4.13. Distribution of Malassezia species isolated from normal skin 
                      according to body sites 
Body site M. furfur M. restricta No growth 
face 25 4 32 
back 10 0 6 
chest 9 0 6 
Upper arm 9 0 7 
neck 1 2 0 
Total 45 6 53 
 
 
Figure 4.18.    26S rDNA PCR giving a product of approximately 580bp before 
                         digestion by restriction enzymes shown with a DNA  
                         SmartLadder (200 to 10000 bp) 
             
 
 
 
1500> 
800> 
 
600> 
 
400> 
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Figure 4.19.   580bp digestion with Cfo I showing 2 species identified: mf =  
                      Malassezia furfur; mr = Malassezia restricta, M = low molecular   
                      weight DNA ladder (25 to 766 bp) 
             
Figure 4.20.  580bp digestion with CfoI showing 2 species identified: mf =  
                     Malassezia furfur; ms = Malassezia sympodialis, M = low  
                     molecular weight DNA ladder (25 to 766 bp) 
 
            
Figure 4.21.   580bp digestion with BstC I showing only Malassezia furfur at  
                      400bp and 180bp, M = low molecular weight DNA ladder (25 to  
                      766 bp) 
            
M   mf  mf   mr  mf   mf   mf   mr  mf mf  mr  mf  mr  mf mf  mf  mf mf mf mf  mf   mf   mf mf  mf  mf  mf   
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250> 
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100> 
  
 
M       ms       ms      mf     mf     M        mf     
mf    mf   
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 CHAPTER FIVE 
Discussion 
5.1. Clinical characteristics of the participants 
The average age of students with PV observed in this study was 16 years and the 
age group with the highest number of students was 14 up to 18 years. This is similar 
to previous studies conducted in Brazil, Dar es Salaam and Bangkok, where the 
highest prevalence of PV was observed in patients aged between 10 and 19 years, 
16 and 19 years and 12 and 21 years respectively.(10, 11, 19, 56, 89) It also agrees 
with past observation of PV as an infection of older teens/adolescents when 
compared with dermatophyte infections.(4, 14, 57, 89) The reason can be attributed 
to the increase in activity of sebaceous glands(15, 25) which is linked with increased 
release of hormones especially androgens in this age group.(10, 149)  
There was no significant difference between age and gender among the participants. 
Also more females than males were observed with PV in this study (M:F 1:1.6). 
Some studies have shown increased prevalence of PV in females;(11, 57, 89) while 
other reports suggest that there is no sex predilection.(3, 4) A major factor that could 
have contributed to the higher prevalence of PV in females in this study was the 
eagerness of the females to be participants. The other contributing factors may be 
the higher use by the female population of occlusive cosmetics namely talcum 
powders as well as skin lightening creams, some of which may also contain 
corticosteroid which is known to impair the integrity of the skin immune surveillance 
against superficial infections. Daily use of cosmetics has been observed to increase 
concentration of carbondioxide in the epidermis thus inducing a change in the 
microflora, producing low skin pH and encourage growth of the Malassezia yeast.(89)  
This study showed that personal grooming habits such as having a daily bath did not 
prevent the development of PV in this environment. All of the students had at least 
one daily bath, about two-third used tap water (running water) and more than half of 
the students used soap to wash daily. This is always expected from school children 
and is a rule usually enforced by their teachers and the Principal of the school. 
Studies from India and the Central African Republic did not observe, similar to this 
study, any direct association with regards to personal hygiene and the development 
or spread of PV infection.(10, 46, 47) However, this is in contrast to a study in this 
environment on prevalence of skin infections and infestations among prison in-mates 
where a significant association was observed with poor hygiene.(53) Meanwhile, the 
humid and hot conditions of the prisons compared to the community may have been 
a confounding factor.  
There was a higher prevalence of PV among those living in low income residential 
areas of Abuja where overcrowding, resulting in poor ventilation and higher 
environmental temperatures could be quite common. Majority of the parents were 
traders which can be regarded as a low income occupation. Some studies have 
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documented a higher prevalence of PV in patients from low socioeconomic 
background; however, similar with results from this study there was no statistically 
significant difference observed by Belec et al. in Central African Republic(10) and 
Jena et al. in India.(24) According to Belec et al, the clinical characteristics of PV did 
not differ distinctly within country or by the type of urbanization in which the patient 
lived.(10, 150)  
This study suggested hyperhidrosis as an important factor in the development of PV.  
Although most of the students after school activity were not sports related, some of 
them were involved in other activities that could lead to excessive sweating such as 
farming and street trading. Most importantly, sweating is common in our environment 
as gadgets that cool the temperature such as air-conditioning and fans are not 
readily available. Presently electricity is also erratic. The average atmospheric 
temperature recording in the time course of the study was as high as 380 C which is 
a strong predisposing environmental factor to PV development.(3, 17, 48, 53, 149) 
None of the students had associated chronic systemic diseases or were in any 
immunocompromised state. 
A family history was associated with the development of PV in this study. About one 
third of the students had at least one member of the nuclear family with a history of 
PV. This was observed more among siblings than parents. A slightly higher result 
was obtained by Rao et al. (38.3%) in India(47) while lower percentages of 22.2% 
and 25%, respectively, were observed by Hafez et al.(21) and Ghosh et al.(46) 
Genetic factor has been linked to increased sebum production in those infected with 
PV.(1, 7, 149) This combines with environmental factors to predispose individuals to 
PV. Meanwhile students with the presence of a family history of PV were significantly 
younger than those without a family history (13.3 vs 13.9 years). This was expected 
and also agrees with previous observations.(21, 45, 47) Unpredictably, the 
relationship between recurring PV and having a positive family history was not 
observed in this study unlike in above mentioned studies. It is worthy to note that 
having a family history of PV was not influenced by socioeconomic status or gender. 
5.2 Clinical features of PV 
The average age of onset of PV in this study was 13.7 years. This is the mean age 
when an increase in sebaceous activity is observed.(25) Although females with PV 
developed the disorder at a slightly younger age than males, this difference was not 
significant. Besides, study by Luebberding et al. observed a significant difference in 
sebum production in both genders, with the production always higher and stable with 
increasing age in the males and progressively decreases over lifetime in the 
females.(151) Meanwhile females begin puberty at an earlier age than males. 
The area of residence of participants from this study had an effect on the age of 
onset of PV. The students who lived in the low income residential part of Abuja with 
poor availability of amenities including housing and increased population were 
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observed to develop PV at a younger mean age of 13.3 years in contrast to those 
living in the more expensive city centre region of Abuja. Belec et al.(10) compared 
the characteristics of PV patients and non-PV patients with their place of residence 
and found no significant difference between the two groups. In contrast, this study 
compared place of residence within PV patients. The earlier age of onset in this 
group of students could be related to poor living conditions and possible persistence 
of poor ventilation and high environmental temperatures; however, further research 
would be needed to confirm this finding. Meanwhile, studies looking at factors that 
could affect the age of onset of PV need to be included in the literature. 
There are four main classes of moisturizers based on their mechanism of action. 
They include the occlusives, humectants, emollients and protein rejuvenators. 
Occlusives provide exogenous barrier for the skin and marked reduction in 
transepidermal water loss (TEWL). A well know prototype of occlusive moisturizers is 
petrolatum. Petrolatum was shown to have an occlusive effect on the skin, stimulate 
skin lipid biosynthesis and permeate all levels of the stratum corneum in a research 
by Ghadially et al.(152) These processes were observed on normal skin and have 
been confirmed by Patzelt(153) and Stamatas et al.(154) However, studies with 
regard to the relationship of petrolatum and Malassezia infection are sparse. 
Koyama et al. was able to demonstrate a florid growth of Malassezia furfur but not of 
Malassezia globosa in a culture plate containing petrolatum.(155) Humectants 
increase water content of the skin by enhancing water absorption from the dermis 
into the epidermis. The absorbed water can easily evaporate into the environment, 
thus producing increased TEWL. The most common humectant is glycerol or 
glycerine which is a major component of most of the body creams used by the 
participants. In this study, about 51% of the students mainly males applied 
petrolatum namely Vaseline® on a daily basis. These students developed PV at a 
younger age than those who did not use Vaseline® (13.3 vs 14.1 years). This 
difference was found to be statistically significant P = 0.004. Meanwhile, a 
statistically significant difference was not observed among those who applied body 
creams routinely.  
Dandruff also known as pityriasis capitis or mild seborrheic dermatitis is a non-
inflammatory scaling condition of the scalp(73) which commonly affects postpubertal 
individuals and has been associated with Malassezia, Acremonium, Penicillium and 
Cryptococcus species hence the good results obtained after treatment with 
antifungals. Non microbial causes of dandruff include dust, heat, cosmetic use 
etc.(73) Studies on the pathogenesis and management of this very common scalp 
disorder are few and inconclusive. This study observed a very high percentage (22%) 
of PV students with concomitant pityriasis capitis; higher than were observed by 
Ghosh and Rao et al. who observed 10% and 11.6%, respectively.(46, 47)  
Generally, not all individuals with Malassezia on their skin have dandruff(156) and 
also the level of Malassezia on the normal scalp tends to be doubled that on dandruff 
scalp.(73) In this study the students who had pityriasis capitis were found to have an 
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earlier age of onset of PV infection (12.6 vs 14.0 years; p=0.001). The reason for this 
association is, however, unclear and may be related to non-studied endogenous 
factors that could predispose these individuals at an earlier age to fungal infections. 
Although the information on the age of onset of pityriasis capitis by this group of 
students was not obtained, it would be interesting to know if there is any relationship 
with the age of onset of PV. Meanwhile, there were no significant differences 
observed between those who had pityriasis capitis and recurring PV; thus the fact 
that an individual has dandruff does not predispose him/her to recurring episodes of 
PV. Probably this could be because the etiological agent of the pityriasis capitis was 
not necessarily the source of the PV. Further studies are needed to clarify this. 
Animals have been observed to have Malassezia infections although the species 
differ slightly from those that infect man,(66, 68) a study have shown that the 
possible transfer of zoophilic Malassezia pachydermatis to human skin is quite 
rare.(157) A small number of the students had regular contact with animals (20%) 
and there was no relationship between having animal contact and PV infection from 
this study.  
On the use of bleaching products by the students, 14.5% of them acknowledged 
their use. These were mainly female students. This is predictable as females are 
known to be more beauty conscious, thus use more cosmetic products than males. It 
is also known that females tend to be disturbed by blemishes on the skin. However, 
the clinical features of PV in this group of students did not differ significantly from the 
other students in the study. According to case-control study reports by some authors, 
pityriasis versicolor is not as common as dermatophyte infections in population who 
use bleaching products.(158, 159)  
Pruritus and tingling sensation are major symptoms associated with PV. Slightly less 
than half of the students in this study had pruritus/tingling sensation (42.8%). Similar 
percentages were also reported by Ingordo et al. in Italian sailors, Rao et al. in India 
and Morais et al. in Brazil.(17, 46, 160) It was also observed in this study that the 
students who sweat excessively are more likely to have associated symptoms of 
pruritus and tingling sensation. Although this association was not found in literature, 
since research in this area is sparse, excessive perspiration could also be 
associated with pruritus as seen in disorders of keratinization. It could also act as a 
confounding factor in PV studies. Another reason for the pruritus could be due to the 
effect of dehydration of the stratum corneum from the increased perspiration. This is 
corroborated by reviews that have shown PV to be more pruritic when lesions are 
exposed to high temperatures. Meanwhile a higher skin humidity provides a better 
growth environment in the skin for Malassezia yeasts.(7) A study by Santana et al. 
correlated pruritus in PV patients with skin type and observed that pruritus was more 
frequent in patients with dehydrated epidermis.(89)  
Recurrence of PV is commonly reported. About two-third of the students had 
recurring episodes. This is similar to reports by Framil and Morais et al.(144, 160) 
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who noted recurrence rate of 67.4% and 52.6%, respectively. However, this study 
did not find significant differences among these students when analysed with regard 
to their use of petrolatum and presence of excessive sweating, as well as having a 
positive family history of PV which had been previously linked to recurrence in PV. It 
is possible that endogenous factors may predispose individuals to recurrent/relapse 
episodes of PV and not only the presence of environmental factors such as 
hyperhidrosis, application of body oils and occlusive dressing.(4) Rao et al. attributed 
the reason for the high recurrence rate in PV infection to the presence of Malassezia 
in individual’s hair follicles.(47) There is need for studies investigating the actual 
factors that predispose individuals to PV recurrence. This is grossly not explored in 
the literature. 
The lesions seen in our study participants were hypopigmented macules which 
usually start perifollicularly as seen in Figure 4.13. This corroborates Rao et al. 
speculation on the presence of Malassezia in individual’s hair follicles. The lesions 
then coalesce to form larger macules. Some of the lesions had a brawny scaly 
appearance especially at areas which were not accessible to scrubbing during a bath. 
Lesions on the face had minimal scaling. Hypopigmentation of PV lesions is a 
common presentation in a darker-skinned population. Akin findings were reported in 
studies conducted in Africa, Brazil, India and Bangkok.(10, 11, 46, 47, 60, 89, 160) 
The reason still remains unclear. This study, comparable with other authors did not 
observe any correlation between the colour of the lesions with personal hygiene, 
clinical features and presence of a family history. 
Most of the lesions were located on the face. This confirms literature reports 
describing facial distribution of PV lesions as common mostly in children and black 
people,(10, 24, 56, 89, 149, 161) in contrast to the rarity of facial involvement in the 
white skinned population. In this study, frequent sites involved by PV were the face, 
back and chest. Parallel findings were noted in studies by Ghosh and Rao et al.(46, 
47) Extensive PV which can be described as PV involvement of 3 or more body 
regions was observed in 8.2% of the students. This is comparable with the study by 
Pönnighaus et al. in Malawi who observed 8.0%(15) and Terragni et al. in Italy who 
observed 8.9%(149) but lower than figure obtained by Jena et al. in India who 
observed extensive PV in 45 (16.6%) children.(24) In this study, students with 
extensive PV were significantly associated with PV symptoms of pruritus and tingling 
sensation. No known similar study has compared PV symptoms with extent of 
distribution of lesions.  Macular pattern of PV lesions as well as follicular, confluent 
and guttate patterns was observed in this study as were observed by other 
authors.(46, 47) Inverse distribution of PV was not detected. 
Medications used by the students were mostly over-the-counter antifungal products. 
Most of these products are sold in combination with highly potent steroids. 
Meanwhile 10.5% of the students used folk remedies to treat PV, particularly 
hydraulic (brake) fluid which has been observed by some studies in Nigeria and 
Botswana as a common means utilized by less educated individuals to treat most 
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skin diseases at home.(52, 162) The students acknowledged clearance of the 
lesions on application of hydraulic fluid, though, there was usually a recurrence. This 
clearance could be due to propylene glycol a common base stock for hydraulic fluids. 
Propylene glycol is one of the several non-specific topical antifungal agents available 
for PV treatment. However, due to the other chemical compounds also found in 
hydraulic fluids, these students need to be informed that dermal exposure to these 
fluids could lead to signs of skin irritation. 
5.3 Health related quality of life (HRQoL) of students with PV 
The total quality of life score observed in this study was 7.39 (95%CI 6.73-8.06) 
which is approximately 25% impairment in HRQoL. This figure is close to the total 
CDLQI score (7.17±3.03) observed in a Nigerian community cross-sectional study of 
children with tinea infection.(163) Comparing this effect with the comparative study 
done by Beattie et al.(164) the level of impairment (25%) caused by PV was higher 
than urticaria (20%) and acne (18%) but lower than psoriasis (30.6%) and atopic 
dermatitis (30.5%).  
According to the health behavior in school aged children (HBSC) 2009/2010 report, 
age, gender, socioeconomic, and environmental differences are significant social 
determinants of health and well-being among young people.(165) In this study, there 
was a significant increase in HRQoL impairment among the students with PV who 
were older than 13 years and those who had PV among member(s) of their nuclear 
family. This was similarly observed in the study by Akinboro et al. where the CDLQI 
score was significantly higher in children with tinea capitis older than 13 years.(163) 
The increase in impairment observed in the students with PV who also had a family 
member with PV could be due to the additional stress they felt having someone they 
care about with a skin disorder. In this study, the difference in gender, social 
environment and level of education did not have a significant effect on their quality of 
life. 
A large percentage of students had recurring PV. They had a lower HRQoL 
impairment than those having PV for the first time. This was unpredictable since 
chronic or recurring skin diseases are expected to produce a negative impact on 
individual’s psychosocial well-being as seen in the study on hand dermatitis and 
psoriasis.(166, 167) Perhaps, since the comparison is between individuals with 
recurring disease and first timers, the anxiety and sensitivity to peoples’ opinion felt 
by the recurring disease individuals had waned with time. More studies are needed 
to further evaluate this aspect because the recurring nature of PV has been 
generally assumed to contribute to the psychosocial well-being of patients.(142)   
It is interesting to observe that students with PV lesions on unexposed parts of the 
body had lower quality of life than those who had on exposed body parts although 
this difference was not statistically significant. This observation was similarly 
documented in the paper of Ludwig et al.(168) in which no significant difference in 
85 
 
quality of life was found associated with the sites of skin lesions. Correspondingly, 
quality of life did not differ significantly between students having hypopigmented PV 
and hyperpigmented PV. This could be because the skin is regarded as a whole and 
indivisible organ; hence no matter the region of the body affected or the colour of the 
lesion, the presence of a skin disorder is a cause of embarrassment and anxiety for 
the patient.(167, 169) 
Although the percentage of students with PV who had reduced self-confidence and 
were ashamed of the lesions was high, the significant impairment in quality of life 
associated with low self-confidence and reduced ability to make friends is, however, 
inconclusive as a comparative study with students without PV would be required.  
The HRQoL impairment correlated positively with the number of body regions 
afflicted with PV. The increase in number of involved sites could be related with the 
disease severity which has been shown to correlate with patients’ quality of life.(163, 
168, 169)  
Students who had pruritus or tingling sensation associated with PV had significantly 
higher CDLQI scores. Pruritus is an important factor affecting QoL,(170) thus it is 
expected that it would impair quality of life and this should be taken into 
consideration when treating patients with PV.  
The leisure category contributed mostly to the quality of life impairment observed in 
this study. Since the burden of skin disease encompasses psychosocial and financial 
consequences on the patients, their families and the society,(171) it is obvious from 
this study that PV was a contributor to the psychosocial burden of the students. The 
treatment category was third in rank as factors that impair quality of life but it did not 
make a statistically significant impact. Generally, skin diseases that itch, have 
unacceptable appearance or not easily treatable tend to significantly impair social 
relations, psychological status and day-to-day activities of patients.(167, 171) 
Unfortunately, a lot of individuals underestimate the effect that PV has on the quality 
of life of adolescents in the Tropics. This should be noted and addressed in its 
management.   
In summary, quality of life determinants in students with PV observed in this study 
included age of the patient, number of episodes of PV infection, existence of a family 
member with PV, number of body regions affected and the presence of associated 
pruritus or tingling sensation. The gender, level of education and the type of 
neighborhood where the students reside did not significantly contribute to their 
quality of life. Overall, this study has demonstrated the negative impact which PV 
has on the quality of life among adolescents and more studies are being called 
especially from areas with high PV prevalence as this knowledge can lead to 
improved patient management. 
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5.4 Identification of Malassezia species 
In this study, three species were identified from PV lesions namely, Malassezia furfur, 
Malassezia restricta and Malassezia sympodialis, of which 81.7% was composed of 
M. furfur. A higher percentage of M. furfur (77.6%) was also observed on non-
lesional skin samples. Two species only were identified from non-lesional skin (M. 
furfur and M. restricta). This observation is quite different from most studies on the 
identification of Malassezia species from PV. These studies have indicated M. 
globosa as the most prevalent causative species.(62, 70, 102, 105, 172-175) They 
were studies from temperate and mediterranean climates of the world, namely, 
Spain, Japan, Bosnia-Herzegovina, Israel, Tunisia and Italy. The few investigations 
where M. furfur have been most prevalent were from tropical and subtropical 
climates such as Thailand, Indonesia, Brazil and Venezuela.(11, 108, 176, 177) 
Furthermore, the method of identification used by these studies from tropical 
climates was based on the physiological and biochemical characteristics of the 
cultured yeast while this study used the molecular analysis method. This difference 
should not affect results obtained just as a study by Romano et al. did not observe 
differences in the identified Malassezia species when comparing conventional 
culture-based with the molecular based methods.(173)  
Further studies from Brazil(106, 107) and Argentina(20) observed M. sympodialis as 
the most prevalent species in PV and this was consistently followed by M. furfur. Yet, 
Crespo-Erchiga et al.(66) agree with the more than 80 years old hypothesis which 
postulates that a second species other than M. globosa (mostly observed in 
temperate climates) could be predominant in warmer and more humid climates. This 
study is subject to their call for larger and reliable studies from a tropical climate to 
test this hypothesis. Not only is M. furfur the most prevalent species in PV lesions, it 
was also the most prevalent on non-lesional skin. By this result, we can conclude 
that M. furfur is the causative agent of PV in Nigerian students. It is possible to 
observe so very little number of Malassezia species per study as was seen in a 
report from Israel where M. globosa was mostly detected in the lesional and non-
lesional skin of patients with PV at a rate of 97.3% and 80.8%, respectively.(175) 
Prevalent studies on identification of Malassezia species from sub-Saharan Africa 
are sparse. The study in Sudan on the molecular epidemiology of Malassezia in 
patients with PV was restricted to the identification of M. globosa and M. 
restricta.(147) Saad et al. looked at the level of colonization of only these 2 species 
using a molecular-based, culture-independent method while comparing diseased 
with healthy individuals. Further studies are required to observe the possible 
prevalence of all Malassezia species and how they compare with the above 
mentioned species and thus determine the most prevalent causative species of PV 
in sub-Saharan Africa. 
In this study, the second most prominent species identified though at very low 
percentage was M. restricta which is in contrast also with most studies where M. 
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sympodialis is, in order of frequency, the second most common species isolated 
from culture.(102, 108, 176)  Also different in this study is the failure to identify M. 
sympodialis from healthy skin. M. sympodialis has been observed to predominate on 
healthy skin of the trunk, both in non-lesional areas in PV patients and healthy 
controls.(66, 72, 157) The reason could be related to the absence of M. globosa 
which is known to be associated almost always with M. sympodialis.(20, 66) 
A comparable report in this study with other authors on the identification of 
Malassezia species is the higher culture and isolation rate of Malassezia obtained 
from the scalp (80%) and chest (68.6%) in contrast with other regions of the body. 
Also similar is the more common recovery of M. restricta from the upper regions of 
the body (scalp, face and neck) than the lower body.(76, 178, 179) The correlation of 
the different species isolated with the clinical characteristics of the participants as 
well as the PV lesions did not reveal any significant difference. This is in line with all 
reported studies on the identification of Malassezia species from patients with PV. 
No distinct feature has been linked with a specific species. 
In this study, the recovery rate of Malassezia species from cultures both from 
lesional and non-lesional sites were 57.6% and 52.7%, respectively, which was most 
comparable to the study by Lim et al.(100) but lower than the yield observed by 
Tarazooie et al.(48) and Nakabayashi et al.(70) This was not predicted as the study 
participants were within the age group when the highest positive culture rate was 
expected. (76, 179) The difference could be related to the sampling technique used 
and the growth conditions of the culture. Similar to the study conducted by Tarazooie 
et al.(48) only single species per culture were identified in this study unlike many 
other studies where more than one species could be recovered from a sample. 
Some of the cultures were covered up by faster growing species of other fungi. It 
was difficult to maintain a pure culture and to discriminate a species from a mixed 
sample, thus, some Malassezia species might have been lost after several 
subcultures. 
5.5 Conclusion 
PV was more prevalent in older teenagers and females. The clinical presentation 
was similar to those of other studies with the mean age at first presentation of 
infection observed at 13.7 years. The age of onset of PV was significantly affected 
by a positive history of PV in genetically related family members, socioeconomic 
status, and the daily use of petrolatum and concomitant presence of pityriasis capitis 
(dandruff). The recurrence of PV among the students and the colour of the lesions 
were not linked with inadequate personal grooming methods, clinical features or 
family history of PV. The facial location of the lesions was more prevalent, a location 
similar with those of other studies of children and black population while the extent of 
distribution of the lesion was associated significantly with presence of pruritus and 
dysesthesia. 
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The quality of life determinants in students with PV observed in this study included 
age of the patient, number of episodes of PV lesions, presence of a family member 
with PV, number of body regions affected and the presence of associated pruritus or 
dysesthesia. The gender, level of education and the type of neighborhood where the 
students lived did not significantly contribute to their quality of life while a moderate 
effect on the students’ HRQoL was observed. 
Only three species were identified from this study with the main prevalent species 
being Malassezia furfur which was observed in both lesional and non-lesional skin 
samples. Finally, as observed in other studies, no correlation was found between the 
species and clinical features of PV lesions. 
5.6  Limitations of the study 
1. This was a cross-sectional study. Most of the information used were as 
related by the students. 
2. Some students did not come forward because they did not want to be 
recognized as having PV. 
3. Poor culture yield of the samples; this could have affected the number in 
species identified as the RFLP-PCR was done on culture results. 
4. The skin scales yield even with the use of the Sellotape was poor in some 
cases. Most were affected by sweat which caused poor Sellotape - skin 
adhesion as well as absent yield on skin scrapping as samples were collected 
in the heat of the afternoon. Most of the lesions especially the facial PV had 
little or no scales. Also the use of sponge and daily bath of the students could 
have resulted in the poor skin scales yield. 
5. There were several contaminations from fast growing species of other fungi 
which covered up the Malassezia species and their subsequent loss after 
several subcultures. 
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CHAPTER SIX 
Recommendations 
1. RFLP-PCR can be used even in tropical climate to identify the different 
species of Malassezia. 
2. Since the culture based PCR yields a little above 50% of species identification, 
and the direct skin scale based PCR requires a good amount of scales which 
could be affected by sweat and personal hygiene practices, a better method 
of sample collection needs to be developed to adequately study the presence 
of PV Malassezia species in a tropical environment. 
3. PV had a negative effect on the quality of life of these students; an effective 
management guideline should be developed and if possible with focus on how 
the factors affecting onset of PV can be controlled. This could reduce its 
prevalence. 
4. Most of the students took daily body bath. There is need for public awareness 
to remove the general believe that PV was associated with poor personal 
hygiene and thus reduce the self-stigmatization of patients. 
5. There is prerequisite for more studies to look into other factors that could 
affect the age of onset of PV. This may probably explain why the infection 
affects certain individuals and spare others even when they share similar 
environment.  
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     APPENDIX I 
 
Patient information on the study: "Correlation of Malassezia species with 
clinical characteristics of pityriasis versicolor" 
 
Principal investigator:  
Dr. Perpetua Ibekwe [MBBS (Ib), FMCP] 
National Hospital, 
Abuja 
Nigeria 
Tel: +2348033192661 
Email: perppy_u@yahoo.com 
 
Abuja, February 05 2013 
 
Dear Participant, 
 
     You have volunteered to participate in the above named study. Please read the 
patient information carefully. You can also request for more information from your 
doctor. 
     Pityriasis versicolor known commonly in Nigeria as “eczema” or “Ugwa” in igbo, 
“Ifo in yoruba”, “Makenkero” in hausa is that light- or dark- colored, flat, usually 
asymptomatic rash found on ones face, upper chest and upper back. It can easily 
return after treatment. 
This rash is actually caused by a fungus called Malassezia and it resides normally in 
the outer part of your skin. This fungus can be found in everyone but for some 
unconfirmed reason it causes this skin infection in only some people. There are 13 
types, also called species of Malassezia which are distributed based on climatic 
conditions, ethnic origin, and body site of the affected individual. There are studies 
conducted in a few countries showing the different species of Malassezia available 
there but none yet from our country Nigeria. 
The species of Malassezia found on one’s skin lesion are known to play a role in the 
clinical characteristics of pityriasis versicolor. Our aim is to describe the clinical 
characteristics of your skin lesion, that is the pityriasis versicolor and to identify the 
associative Malassezia. 
To this end, we wish to obtain skin scale samples from the region which has the rash 
by the use of swabs/sellotape. I assure you that this method is safe and does not 
bring you to any bodily harm.   
The scales are cultured in a special medium where we expect this fungus to grow. 
These grown fungal cells are further analyzed by observing their physical 
characteristics through the microscope. These will be done at the laboratory of the 
Department of Microbiology, National Hospital, Abuja. Afterwards, we will carry out 
molecular analysis of the same fungal cells to identify their species. This part will be 
done at the laboratory of the dermatology hospital of the Ludwig Maximilian 
University, Munich, Germany. 
The data samples (skin scrape/cultured fungus/isolated material) will be destroyed 
not later than one year after their evaluation. Despite the isolation of genetic material 
from the fungi, no genetic studies of human genes are being made.  
Participation is voluntary and you may withdraw your consent at any time and 
without notice. 
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We will greatly appreciate your voluntary participation in this research as it will 
support our efforts to broaden our knowledge on pityriasis versicolor and Malassezia 
from an environment such as ours and thus improve on better patient management. 
For inquiries, please contact us at any time. 
Dr. Perpetua Ibekwe 
 
 
Informed consent on the study: "Correlation of Malassezia species with 
clinical characteristics of pityriasis versicolor" 
 
 
Patient Name: 
 
Patient Address:  
 
 
I have been informed verbally and in writing about the above named study by the 
physician named below. I have read through the written patient information. I also 
understand the voluntary nature of my participation and am aware of my right to 
revoke my consent at any time without prejudice. 
My consent is being requested to collect skin samples from the pityriasis versicolor 
lesions on my body. The nature of the investigations to be carried out on the 
samples has been explained to me. 
I have noticed that genetic material will be isolated and analyzed only from the fungal 
cells grown from the skin sample. The extracted biological material from fungi on my 
skin is destroyed completely in a year. 
 
I have a copy of the full Patient Information for this study and a signed copy of this 
consent form. 
 
 
 
 
_________________________      ________________________ 
Date, signature of participant                                        Signature of the doctor  
 
 
 
 
____________________________ 
Date, signature of parent/guardian 
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Data protection statement 
 
 
In this study, the rules on medical confidentiality and privacy are respected. The 
collected data will not include personal details (i.e., neither your name nor your 
initials or date of birth will be used), just some medical details related to pityriasis 
versicolor. An identification of the participant from the fungal sample will be 
impossible (all data will be irreversibly anonymized). For this reason, in case you 
wish to withdraw your consent after anonymization, the data cannot be identified and 
destroyed any more.  
Only the principal investigator, Dr. Perpetua Ibekwe will have access to the original 
medical data. The documents will be in paper form at the Department of 
Microbiology, National Hospital, Abuja, Nigeria. It will be kept for up to 10 years after 
completion or termination of the study in a room inaccessible to unauthorized 
persons. In the case of publications of the study results, the confidentiality of 
personal information is guaranteed by the anonymization. 
 
I hereby agree for my medical data to be collected in this study and to be 
stored in paper form in the Department of Microbiology, National Hospital, 
Abuja. They may be used according to the information given in the patient 
information above. I hereby agree that the medical data collected from my 
medical information and skin sample can be reported in accordance with the 
agreed patient information. 
 
 
 
 
__________________________    ____________________ 
Date, signature of participant    signature of the doctor 
 
 
 
 
____________________________ 
Date, signature of parent/guardian 
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APPENDIX II 
 
QUESTIONAIRE ON PITYRIASIS VERSICOLOR  
(please fill up or tick where appropriate) 
1. ID No.__________ 
2. Sex  M__  F___ 
3. Age______ 
4. Where do you live? ___________________________________________ 
5. Do you live in a Flat, Bungalow, Duplex, Face-me-I-face-you, or_______(circle 
one only) 
6. How many rooms are in your house _______ 
7. How many people in total live in your house _______ 
8. Tribe ______________ State of origin___________ 
9. Class in the school _________________ 
10. Do you live with your parents_____ or guardian_____ 
11. Level of education of parents/guardian: University/college of ducation/polytechnic 
                                                                      Secondary school 
                                                                      Primary school 
                                                                      None  
12. Occupation (please be specific) of  
                         Mother:_____________  
                         Father:_______________  
                         Guardian:____________ 
13. What do you normally do after school: Do sports___, Do household chores____ 
                                                                    Watch TV____,  Go to the farm_____ 
                                                                    Visit friends__,  Have afternoon naps__ 
                                                                    Read novels___ Sell things in market___ 
                                                                    Others (pls specify)____________ 
14. Personal habits: Tick the appropriate answers (you can tick more than one) 
       I take my bath everyday:     YES  NO   
       I use tap water to bath:    YES  NO 
       I use sponge to scrub my body:   YES  NO 
I use ordinary toilet soap to bath:  YES  NO 
I use medicated soap to bath:   YES  NO 
I use talcum powder everyday:   YES  NO 
I use body cream after bathing:   YES  NO 
I use skin toning/bleaching body creams: YES  NO 
I use vaseline:        YES  NO 
I share my towels and cloths:   YES  NO 
I sleep alone on my bed:    YES  NO 
I sweat a lot during the day:   YES  NO  
I sweat a lot at night:    YES  NO 
The cloths I wear make me sweat:  YES  NO 
I have PV during the hamattan season____ and/or rainy season____ 
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15. My PV is worse during the hamattan season____ and/or rainy season______ 
16. I noticed the rash when I was __________ years old 
17. Which parts of your body do you have PV____________________________ 
18. Are you ashamed of the lesions? Yes____   No____ 
19. Does the presence of the lesions reduce your self-confidence? Yes___ No___ 
20. Has the lesions prevented you from making friends? Yes____   No_____ 
21. Should the lesions be treated? Yes___   No___ 
22. What did you use to treat your PV:  drugs__,    herbs__,  
battery water__,   engine oil__ 
antifungal creams___ others____ 
23. Course of the lesions. Please tick the approriate answers (you can tick more 
than one) 
The lesions continue to stay without treatment_______ 
The lesions continue to stay even with treatment_____ 
The lesions returns after treament____  
The lesions disappears without treatment and then returns_____ 
24. The lesions cause itching sensation___ tingling sensation ___ no 
sensation___ 
25. There is someone in my family who has PV. Yes____   No_____                   
If yes, is it your: Father / Mother / brothers / sisters (circle the appropriate 
ones) 
26. Do you have any other sickness? Yes / No   If yes ___________________ 
27. Do you have dandruff? Yes____   No____  
28. Do you have a House pet? Yes / No If yes Dog/Cat/Others___________ 
29. Do you have regular contact with animals Yes____ No____ 
30. Over the last week, how itchy, "scratchy",  Very much  □ 
sore or painful has your skin been?     Quite a lot  □ 
          Only a little  □ 
         Not at all  □ 
 
31. Over the last week, how embarrassed   Very much  □ 
or self-conscious, upset or sad have you    Quite a lot  □ 
been because of your skin?      Only a little  □ 
         Not at all  □ 
 
32. Over the last week, how much have your    Very much  □ 
skin affected your friendships?     Quite a lot  □ 
         Only a little  □ 
         Not at all  □ 
 
33. Over the last week, how much have you changed  Very much  □ 
or worn different or special clothes          Quite a lot  □ 
because of your skin?      Only a little  □ 
         Not at all  □ 
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34. Over the last week, how much have your    Very much  □ 
skin trouble affected going out, playing,   Quite a lot  □ 
or doing hobbies?      Only a little  □ 
         Not at all  □ 
 
35. Over the last week, how much have you    Very much  □ 
avoided football or other sports because   Quite a lot  □ 
of your skin trouble?      Only a little  □ 
         Not at all  □ 
 
36. Last week,      If school time: Over the   Prevented school             □     
was it             last week, how much did   Very much                        □ 
school time?        your skin problem affect your   Quite a lot                □ 
        school work?           Only a little                     □ 
   OR         Not at all           □ 
 
was it          If holiday time: How much        Very much  □ 
holiday time?         over the last week, have your     Quite a lot  □ 
          skin problem interfered with      Only a little  □ 
          your enjoyment of the holiday?   Not at all  □ 
 
37. Over the last week, how much trouble   Very much  □ 
have you had because of your skin with   Quite a lot  □ 
other people calling you names, teasing,   Only a little  □ 
bullying, asking questions or avoiding you?  Not at all  □ 
 
38. Over the last week, how much have your sleep   Very much  □ 
been affected by your skin problem?    Quite a lot  □ 
         Only a little  □ 
         Not at all  □ 
 
39. Over the last week, how much of a     Very much  □ 
problem has the treatment for your     Quite a lot  □ 
skin been?       Only a little  □ 
          Not at all  □ 
Please check that you have answered EVERY question. Thank you.  
©AY Finlay, GK Khan, April 1992 www.dermatology.org.uk. 
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EXAMINATION ( This will be done by me) 
40. Colour of rash               Hypopigmented_____          Hyperpigmented_____ 
41. Pattern of lesion:  Macular___   
Follicular___  
Confluent___   
Guttate_____ 
42. Location of rash ________________________________________________ 
 
43. Other Dermatological disorders present____________________________ 
 
44. Skin scraping location:  Lesion_____________   
Nonlesion_________ 
 
45. Microscopy:  predominant morphology______  
size______  
budding base______ 
46. Wood’lamp: Positive_________   Negative________ 
47. Culture Macroscopy:  Shape_________   
Size_______   
Color consistency__________ 
                                           Characteristics of surrounding media____________ 
48. Species identified ____________________________________________ 
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